Bengt Glimelius

Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Palmer, Daniel H.; Jackson, Richard; Springfeld, Christoph; Ghaneh, Paula et al.

Ingår i Journal of Clinical Oncology, s. 1240-1253, 2025

• DOI för Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
• Ladda ner fulltext (pdf) av Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Prognostic genome and transcriptome signatures in colorectal cancers

Nunes, Luís; Li, Fuqiang; Wu, Meizhen; Luo, Tian et al.

Ingår i Nature, s. 137-146, 2024

• DOI för Prognostic genome and transcriptome signatures in colorectal cancers

Comment on the RAPIDO Trial Point-Counterpoint Debate

Nilsson, Per J.; van Etten, Boudewijn; Hospers, Geke A. P.; Marijnen, Corrie A. M. et al.

Ingår i Diseases of the Colon & Rectum, 2024

• DOI för Comment on the RAPIDO Trial Point-Counterpoint Debate

Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort

Doroudian, Sepehr; Osterman, Erik; Glimelius, Bengt

Ingår i Annals of Surgical Oncology, s. 5570-5584, 2024

• DOI för Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort
• Ladda ner fulltext (pdf) av Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort

Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer

Nunes, Luís; Mørkved Stenersen, Jakob; Kryeziu, Kushtrim; Sjöblom, Tobias et al.

Ingår i Molecular Cancer, 2024

• DOI för Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer
• Ladda ner fulltext (pdf) av Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer

Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Palmer, Daniel H.; Jackson, Richard; Springfeld, Christoph; Ghaneh, Paula et al.

Ingår i Journal of Clinical Oncology, s. 1240-1253, 2025

• DOI för Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
• Ladda ner fulltext (pdf) av Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Prognostic genome and transcriptome signatures in colorectal cancers

Nunes, Luís; Li, Fuqiang; Wu, Meizhen; Luo, Tian et al.

Ingår i Nature, s. 137-146, 2024

• DOI för Prognostic genome and transcriptome signatures in colorectal cancers

Comment on the RAPIDO Trial Point-Counterpoint Debate

Nilsson, Per J.; van Etten, Boudewijn; Hospers, Geke A. P.; Marijnen, Corrie A. M. et al.

Ingår i Diseases of the Colon & Rectum, 2024

• DOI för Comment on the RAPIDO Trial Point-Counterpoint Debate

Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort

Doroudian, Sepehr; Osterman, Erik; Glimelius, Bengt

Ingår i Annals of Surgical Oncology, s. 5570-5584, 2024

• DOI för Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort
• Ladda ner fulltext (pdf) av Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort

Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer

Nunes, Luís; Mørkved Stenersen, Jakob; Kryeziu, Kushtrim; Sjöblom, Tobias et al.

Ingår i Molecular Cancer, 2024

• DOI för Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer
• Ladda ner fulltext (pdf) av Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer

Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial

Zwart, Wouter H.; Temmink, Sofieke J. D.; Hospers, Geke A. P.; Marijnen, Corrie A. M. et al.

Ingår i European Journal of Cancer, 2024

• DOI för Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
• Ladda ner fulltext (pdf) av Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial

Implications of pretreatment extramural venous invasion in rectal cancer patients: A population-based study

Rutegard, Martin; Matthiessen, Peter; Glimelius, Bengt; Blomqvist, Lennart

Ingår i Colorectal Disease, s. 1388-1396, 2024

• DOI för Implications of pretreatment extramural venous invasion in rectal cancer patients: A population-based study
• Ladda ner fulltext (pdf) av Implications of pretreatment extramural venous invasion in rectal cancer patients: A population-based study

Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer

Hammarström, Klara; Nunes, Luís; Mathot, Lucy; Mezheyeuski, Artur et al.

Ingår i International Journal of Cancer, s. 40-53, 2024

• DOI för Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
• Ladda ner fulltext (pdf) av Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer

Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

Glimelius, Bengt; Khan, Tanweera Shaheena; Adolfsson, Karin; Angenete, Eva et al.

Ingår i eClinicalMedicine, 2024

• DOI för Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)
• Ladda ner fulltext (pdf) av Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)

Kinos, Sampsa; Hagman, Helga; Halonen, Päivi; Soveri, Leena-Maija et al.

Ingår i Acta Oncologica, s. 248-258, 2024

• DOI för Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)
• Ladda ner fulltext (pdf) av Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)

The effect of BRAF^V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer: A post-hoc exploratory analysis of the randomized NORDIC9-study

Liposits, Gabor; Winther, Stine B.; Ryg, Jesper; Skuladottir, Halla et al.

Ingår i Journal of Geriatric Oncology, 2024

• DOI för The effect of BRAF^V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer: A post-hoc exploratory analysis of the randomized NORDIC9-study
• Ladda ner fulltext (pdf) av The effect of BRAF^V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer: A post-hoc exploratory analysis of the randomized NORDIC9-study

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

Aho, Sonja; Österlund, Emerik; Ristimäki, Ari; Nieminen, Lasse et al.

Ingår i Cancers, 2024

• DOI för Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)
• Ladda ner fulltext (pdf) av Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma

Sandberg, Emma; Nunes, Luís; Edqvist, Per-Henrik; Mathot, Lucy et al.

Ingår i Cancers, 2024

• DOI för Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma
• Ladda ner fulltext (pdf) av Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma

Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

Österlund, Emerik; Ristimäki, Ari; Mäkinen, Markus J.; Kytölä, Soili et al.

Ingår i International Journal of Cancer, s. 488-503, 2024

• DOI för Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts
• Ladda ner fulltext (pdf) av Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy: The randomized NORDIC9-study

Liposits, Gabor; Ryg, Jesper; Skuladottir, Halla; Winther, Stine B. et al.

Ingår i Journal of Geriatric Oncology, 2023

• DOI för Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy: The randomized NORDIC9-study
• Ladda ner fulltext (pdf) av Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy: The randomized NORDIC9-study

Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome

Enblad, Malin; Pál Egerszegi, Péter; Birgisson, Helgi; Sjöblom, Tobias et al.

Ingår i Cancers, 2023

• DOI för Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome
• Ladda ner fulltext (pdf) av Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)

Lehtomaki, Kaisa; Soveri, Leena-Maija; Österlund, Emerik; Lamminmaki, Annamarja et al.

Ingår i Journal of Clinical Medicine, 2023

• DOI för Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)
• Ladda ner fulltext (pdf) av Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)

The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancerdresults from the RAPIDO trial

Dijkstra, E. A.; Zwart, W. H.; Nilsson, P. J.; Putter, H. et al.

Ingår i ESMO Open, 2023

• DOI för The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancerdresults from the RAPIDO trial

Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study

Shahrivar, Mehrnoosh; Weibull, Caroline E.; Ekström Smedby, Karin; Glimelius, Bengt et al.

Ingår i Cancer Medicine, s. 315-324, 2023

• DOI för Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study
• Ladda ner fulltext (pdf) av Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study

Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer

Ljunggren, Malin; Weibull, Caroline E.; Palmer, Gabriella; Österlund, Emerik et al.

Ingår i International Journal of Cancer, s. 363-373, 2023

• DOI för Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer
• Ladda ner fulltext (pdf) av Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery

Dijkstra, Esmee A.; Nilsson, Per J.; Hospers, Geke A. P.; Bahadoer, Renu R. et al.

Ingår i Annals of Surgery, 2023

• DOI för Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery

CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research

Weibull, Caroline E.; Boman, Sol Erika; Glimelius, Bengt; Syk, Ingvar et al.

Ingår i Acta Oncologica, s. 342-349, 2023

• DOI för CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research
• Ladda ner fulltext (pdf) av CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

Morton, Dion; Seymour, Matthew; Magill, Laura; Handley, Kelly et al.

Ingår i Journal of Clinical Oncology, s. 1541-+, 2023

• DOI för Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

Authors' reply-A sensitivity analysis of the RAPIDO clinical trial

Dijkstra, E. A.; Zwart, W. H.; Putter, H.; Marijnen, C. A. M. et al.

Ingår i Annals of Oncology, s. 446-447, 2023

• DOI för Authors' reply-A sensitivity analysis of the RAPIDO clinical trial

Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial

Bahadoer, Renu R.; Hospers, Geke A. P.; Marijnen, Corrie A. M.; Peeters, Koen C. M. J. et al.

Ingår i European Journal of Cancer, s. 139-149, 2023

• DOI för Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial
• Ladda ner fulltext (pdf) av Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Mezheyeuski, Artur; Backman, Max; Mattsson, Johanna Sofia Margareta; Martin-Bernabe, Alfonso et al.

Ingår i EBioMedicine, 2023

• DOI för An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
• Ladda ner fulltext (pdf) av An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study

Imam, Israa; Hammarström, Klara; Glimelius, Bengt

Ingår i Cancers, 2023

• DOI för Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study
• Ladda ner fulltext (pdf) av Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Berndt, Sonja; Vijai, Joseph; Benavente, Yolanda; Camp, Nicola J. et al.

Ingår i Leukemia, s. 2835-2844, 2022

• DOI för Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study

Lehtomaki, Kaisa; Stedt, Hanna P.; Österlund, Emerik; Muhonen, Timo et al.

Ingår i Cancers, 2022

• DOI för Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study
• Ladda ner fulltext (pdf) av Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study

Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study

Hamfjord, Julian; Myklebust, Tor Age; Larsen, Inger Kristin; Kure, Elin H. et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 342-351, 2022

• DOI för Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
• Ladda ner fulltext (pdf) av Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study

Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)

Pfeiffer, Per; Lustberg, Maryam; Nasstrom, Jacques; Carlsson, Stefan et al.

Ingår i JNCI CANCER SPECTRUM, 2022

• DOI för Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)

Mucinous rectal cancers: clinical features and prognosis in a population-based cohort

Enblad, Malin; Hammarström, Klara; Folkesson, Joakim; Imam, Israa et al.

Ingår i BJS Open, 2022

• DOI för Mucinous rectal cancers: clinical features and prognosis in a population-based cohort
• Ladda ner fulltext (pdf) av Mucinous rectal cancers: clinical features and prognosis in a population-based cohort

Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study

Ljunggren, Malin; Weibull, Caroline E.; Rosander, Emma; Palmer, Gabriella et al.

Ingår i BMC Cancer, 2022

• DOI för Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
• Ladda ner fulltext (pdf) av Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study

Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer

Österlund, Emerik; Glimelius, Bengt

Ingår i Acta Oncologica, s. 1278-1288, 2022

• DOI för Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer
• Ladda ner fulltext (pdf) av Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer

KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

Österlund, Emerik; Ristimaki, Ari; Kytola, Soili; Kuopio, Teijo et al.

Ingår i Frontiers in Oncology, 2022

• DOI för KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer
• Ladda ner fulltext (pdf) av KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients

Aasebø, Kristine; Bruun, Jarle; Bergsland, Christian H; Nunes, Luís et al.

Ingår i British Journal of Cancer, s. 48-56, 2022

• DOI för Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients

Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial

Dijkstra, Esmee A.; Hospers, Geke A. P.; Kranenbarg, Elma Meershoek-Klein; Fleer, Joke et al.

Ingår i Radiotherapy and Oncology, s. 69-76, 2022

• DOI för Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial
• Ladda ner fulltext (pdf) av Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt et al.

Ingår i Journal of Clinical Oncology, s. 1487-1496, 2022

• DOI för Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
• Ladda ner fulltext (pdf) av Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters

Karimi, Masoud; Osterlund, Pia; Hammarström, Klara; Imam, Israa et al.

Ingår i Cancers, 2022

• DOI för Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters
• Ladda ner fulltext (pdf) av Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

Osterlund, P.; Kinos, S.; Pfeiffer, P.; Salminen, T. et al.

Ingår i ESMO Open, 2022

• DOI för Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
• Ladda ner fulltext (pdf) av Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study

Liposits, Gabor; Skuladottir, Halla; Ryg, Jesper; Winther, Stine Braendegaard et al.

Ingår i Journal of Clinical Medicine, 2022

• DOI för The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study
• Ladda ner fulltext (pdf) av The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study

Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus

Lambregts, Doenja M. J.; Bogveradze, Nino; Blomqvist, Lennart K.; Fokas, Emmanouil et al.

Ingår i European Radiology, s. 4991-5003, 2022

• DOI för Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus
• Ladda ner fulltext (pdf) av Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus

Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence

Elliot, Anders H.; Othman, Barwar N.; Suzuki, Chikako; Blomqvist, Lennart et al.

Ingår i Anticancer Research, s. 2459-2465, 2021

• DOI för Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence

Quality of life assessments in clinical practice using either the EORTC-QLQ-C30 or the SEIOQL-DW: a randomized study

Kettis, Åsa; Fagerlind, Hanna; Frodin, Jan-Erik; Glimelius, Bengt et al.

Ingår i Journal of Patient-Reported Outcomes, 2021

• DOI för Quality of life assessments in clinical practice using either the EORTC-QLQ-C30 or the SEIOQL-DW: a randomized study
• Ladda ner fulltext (pdf) av Quality of life assessments in clinical practice using either the EORTC-QLQ-C30 or the SEIOQL-DW: a randomized study

Does exercise intensity matter for fatigue during (neo)adjuvant cancer treatment?: The PhysCan randomized clinical trial

Demmelmaier, Ingrid; Brooke, Hannah L.; Henriksson, Anna; Mazzoni, Anne-Sophie et al.

Ingår i Scandinavian Journal of Medicine and Science in Sports, s. 1144-1159, 2021

• DOI för Does exercise intensity matter for fatigue during (neo)adjuvant cancer treatment?: The PhysCan randomized clinical trial
• Ladda ner fulltext (pdf) av Does exercise intensity matter for fatigue during (neo)adjuvant cancer treatment?: The PhysCan randomized clinical trial

Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis

Hanna, Catherine R.; Robles-Zurita, Jose A.; Briggs, Andrew; Harkin, Andrea et al.

Ingår i Clinical colorectal cancer, s. 236-244, 2021

• DOI för Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis
• Ladda ner fulltext (pdf) av Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis

Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma

Schernberg, Antoine; Vernerey, Dewi; Goldstein, David; van Laethem, Jean-Luc et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, s. 1022-1031, 2021

• DOI för Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma

Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma

Giraud, Paul; Racadot, Severine; Vernerey, Dewi; Goldstein, David et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, s. 993-1002, 2021

• DOI för Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

Micke, Patrick; Strell, Carina; Mattsson, Johanna Sofia Margareta; Martin-Bernabe, Alfonso et al.

Ingår i EBioMedicine, 2021

• DOI för The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
• Ladda ner fulltext (pdf) av The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

TOSCA-a delicious Swedish almond cake, an Italian opera and an Italian trial with important new data

Glimelius, Bengt

Ingår i Annals of Oncology, s. 6-8, 2021

• DOI för TOSCA-a delicious Swedish almond cake, an Italian opera and an Italian trial with important new data

Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer

Hamfjord, Julian; Guren, Tormod Kyrre; Glimelius, Bengt; Sorbye, Halfdan et al.

Ingår i International Journal of Cancer, s. 1385-1397, 2021

• DOI för Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer
• Ladda ner fulltext (pdf) av Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer

Interpreting the RAPIDO trial: factors to consider – Author's Reply

Bahadoer, Renu R.; Dijkstra, Esmée A.; van Etten, Boudewijn; Marijnen, Corrie A. M. et al.

Ingår i The Lancet Oncology, 2021

• DOI för Interpreting the RAPIDO trial: factors to consider – Author's Reply

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Bahadoer, Renu R.; Dijkstra, Esmee A.; van Etten, Boudewijn; Marijnen, Corrie A. M. et al.

Ingår i The Lancet Oncology, s. 29-42, 2021

• DOI för Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer

Osterman, Erik; Hammarström, Klara; Imam, Israa; Österlund, Emerik et al.

Ingår i Acta Oncologica, s. 842-849, 2021

• DOI för Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer

Accurate population-based model for individual prediction of colon cancer recurrence

Osterman, Erik; Ekström, Joakim; Sjöblom, Tobias; Kørner, Hartwig et al.

Ingår i Acta Oncologica, s. 1241-1249, 2021

• DOI för Accurate population-based model for individual prediction of colon cancer recurrence

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy: The Randomized NORDIC9-Study

Liposits, Gabor; Eshoj, Henrik Rode; Möller, Sören; Braendegaard Winther, Stine et al.

Ingår i Cancers, 2021

• DOI för Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy: The Randomized NORDIC9-Study
• Ladda ner fulltext (pdf) av Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy: The Randomized NORDIC9-Study

The Immune Landscape of Colorectal Cancer

Mezheyeuski, Artur; Micke, Patrick; Martin-Bernabe, Alfonso; Backman, Max et al.

Ingår i Cancers, 2021

• DOI för The Immune Landscape of Colorectal Cancer
• Ladda ner fulltext (pdf) av The Immune Landscape of Colorectal Cancer

hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA

Aughton, Karen; Elander, Nils O.; Evans, Anthony; Jackson, Richard et al.

Ingår i Cancers, 2021

• DOI för hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
• Ladda ner fulltext (pdf) av hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA

A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer

Hammarström, Klara; Imam, Israa; Mezheyeuski, Artur; Ekström, Joakim et al.

Ingår i Cancers, 2021

• DOI för A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer
• Ladda ner fulltext (pdf) av A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer

Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?

Imam, Israa; Hammarström, Klara; Sjöblom, Tobias; Glimelius, Bengt

Ingår i Radiotherapy and Oncology, s. 70-77, 2021

• DOI för Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?
• Ladda ner fulltext (pdf) av Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?

Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial

Erlandsson, Johan; Fuentes, Stina; Radu, Calin; Frödin, Jan-Erik et al.

Ingår i BJS Open, 2021

• DOI för Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial
• Ladda ner fulltext (pdf) av Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial

Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis

Nunes, Luís; Aasebø, Kristine; Mathot, Lucy; Ljungström, Viktor et al.

Ingår i Acta Oncologica, s. 417-426, 2020

• DOI för Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis
• Ladda ner fulltext (pdf) av Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis

Genetically Determined Height and Risk of Non-hodgkin Lymphoma

Moore, Amy; Kane, Eleanor; Wang, Zhaoming; Panagiotou, Orestis A. et al.

Ingår i Frontiers in Oncology, 2020

• DOI för Genetically Determined Height and Risk of Non-hodgkin Lymphoma
• Ladda ner fulltext (pdf) av Genetically Determined Height and Risk of Non-hodgkin Lymphoma

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

Aasebo, Kristine; Dragomir, Anca; Sundström, Magnus; Mezheyeuski, Artur et al.

Ingår i Frontiers in Oncology, 2020

• DOI för CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
• Ladda ner fulltext (pdf) av CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid; Björkholm, Magnus et al.

Ingår i British Journal of Haematology, s. 685-691, 2020

• DOI för No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study

Mezheyeuski, Artur; Pontén, Fredrik; Edqvist, Per-Henrik D; Sundström, Magnus et al.

Ingår i Acta Oncologica, s. 284-290, 2020

• DOI för Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study
• Ladda ner fulltext (pdf) av Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study

Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort

Osterman, Erik; Mezheyeuski, Artur; Sjöblom, Tobias; Glimelius, Bengt

Ingår i Annals of Surgical Oncology, s. 1036-1045, 2020

• DOI för Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort
• Ladda ner fulltext (pdf) av Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort

Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version

Dahl, Olav; Myklebust, Mette Pernille; Dale, Jon Espen; Leon, Otilia et al.

Ingår i Acta Oncologica, s. 1016-1023, 2020

• DOI för Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version

Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma

Liu, Zhiwei; Jarrett, Ruth F.; Hjalgrim, Henrik; Proietti, Carla et al.

Ingår i International Journal of Cancer, s. 608-618, 2020

• DOI för Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma

ASO Author Reflections: Emerging Risk Factors in Colon Cancer — End of the Line for Clinomics?

Osterman, Erik; Glimelius, Bengt

Ingår i Annals of Surgical Oncology, s. 1046-1047, 2020

• DOI för ASO Author Reflections: Emerging Risk Factors in Colon Cancer — End of the Line for Clinomics?
• Ladda ner fulltext (pdf) av ASO Author Reflections: Emerging Risk Factors in Colon Cancer — End of the Line for Clinomics?

Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer

Herrera, Mercedes; Mezheyeuski, Artur; Villabona, Lisa; Corvigno, Sara et al.

Ingår i Cancers, 2020

• DOI för Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer
• Ladda ner fulltext (pdf) av Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer

Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial

van der Valk, Maxime J. M.; Marijnen, Corrie A. M.; van Etten, Boudewijn; Dijkstra, Esmee A. et al.

Ingår i Radiotherapy and Oncology, s. 75-83, 2020

• DOI för Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

Marijnen, C. A. M.; Peters, F. P.; Roedel, C.; Bujko, K. et al.

Ingår i Radiotherapy and Oncology, s. 213-215, 2020

• DOI för International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients

Sclafani, Francesco; Wilson, Sanna Hulkki; Cunningham, David; De Castro, David Gonzalez et al.

Ingår i International Journal of Cancer, s. 94-102, 2020

• DOI för Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients

Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients

Aasebö, Kristine Ö.; Dragomir, Anca; Sundström, Magnus; Mezheyeuski, Artur et al.

Ingår i Cancer Medicine, s. 3623-3635, 2019

• DOI för Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients
• Ladda ner fulltext (pdf) av Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients

Determining the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelines

Hammarström, Klara; Imam, Israa; Korsavidou Hult, Nafsika; Ekström, Joakim et al.

Ingår i Radiotherapy and Oncology, s. 106-112, 2019

• DOI för Determining the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelines

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

Din, Lennox; Sheikh, Mohammad; Kosaraju, Nikitha; Smedby, Karin Ekstrom et al.

Ingår i Genetic Epidemiology, s. 844-863, 2019

• DOI för Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy

Hamfjord, J.; Guren, T. K.; Dajani, O.; Johansen, J. S. et al.

Ingår i Annals of Oncology, s. 1088-1095, 2019

• DOI för Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
• Ladda ner fulltext (pdf) av Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT

Ivesono, Timothy; Boydo, Kathleen A.; Kerro, Rachel S.; Robles-Zuritao, Jose et al.

Ingår i Health Technology Assessment, s. 1-88, 2019

• DOI för 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT
• Ladda ner fulltext (pdf) av 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT

Definition of the Rectum An International, Expert-based Delphi Consensus

D'Souza, Nigel; Babberich, Michael P. M. de Neree Tot; d'Hoore, Andre; Tiret, Emmanuel et al.

Ingår i Annals of Surgery, s. 955-959, 2019

• DOI för Definition of the Rectum An International, Expert-based Delphi Consensus

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

Jones, Robert P.; Psarelli, Eftychia-Eirini; Jackson, Richard; Ghaneh, Paula et al.

Ingår i JAMA Surgery, s. 1038-1048, 2019

• DOI för Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer

Mezheyeuski, Artur; Hrynchyk, Ina; Herrera, Mercedes; Karlberg, Mia et al.

Ingår i British Journal of Cancer, s. 303-311, 2019

• DOI för Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer

Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores

Gargiulo, Piera; Dietrich, Daniel; Herrmann, Richard; Bodoky, Gyorgy et al.

Ingår i THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019

• DOI för Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores
• Ladda ner fulltext (pdf) av Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores

An audit of performance, interpretation, and influence of pretherapeutic MRI in rectal cancer: a Swedish population-based cohort study

Elliot, Anders H.; Blomqvist, Lennart; Sigurdsson, Arni; Martling, Anna et al.

Ingår i Acta Radiologica, s. 955-961, 2019

• DOI för An audit of performance, interpretation, and influence of pretherapeutic MRI in rectal cancer: a Swedish population-based cohort study

Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy

Erlandsson, J.; Pettersson, D.; Glimelius, Bengt; Holm, T. et al.

Ingår i British Journal of Surgery, s. 1248-1256, 2019

• DOI för Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy

Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial

Erlandsson, Johan; Lorinc, Ester; Ahlberga, Madelene; Pettersson, David et al.

Ingår i Radiotherapy and Oncology, s. 178-186, 2019

• DOI för Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial

The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma

Ghaneh, Paula; Kleeff, Jorg; Halloran, Christopher M.; Raraty, Michael et al.

Ingår i Annals of Surgery, s. 520-529, 2019

• DOI för The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma

Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancer

Glimelius, Bengt; Nygren, Peter

Ingår i Acta Oncologica, s. 395-397, 2019

• DOI för Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancer

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full- dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

Whither, Stine Braendegaard; Liposits, Gabor; Skuladottir, Haifa; Hofsli, Eva et al.

Ingår i The Lancet Gastroenterology & Hepatology, s. 376-388, 2019

• DOI för Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full- dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study

Majano, Sara Benitez; Di Girolamo, Chiara; Rachet, Bernard; Maringe, Camille et al.

Ingår i The Lancet Oncology, s. 74-87, 2019

• DOI för Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study
• Ladda ner fulltext (pdf) av Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study

Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx^®): a placebo-controlled randomised phase II study (PLIANT)

Glimelius, Bengt; Manojlovic, Nebojsa; Pfeiffer, Per; Mosidze, Baadur et al.

Ingår i Acta Oncologica, s. 393-402, 2018

• DOI för Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx^®): a placebo-controlled randomised phase II study (PLIANT)

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; Alafuzoff, Irina et al.

Ingår i Acta Oncologica, s. 187-194, 2018

• DOI för U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
• Ladda ner fulltext (pdf) av U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?

Bhoday, J.; Glimelius, Bengt; Tait, D.; Glynne-Jones, R. et al.

Ingår i Colorectal Disease, s. 97-99, 2018

• DOI för Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

McMaster, Mary L.; Berndt, Sonja; Zhang, Jianqing; Slager, Susan L. et al.

Ingår i Nature Communications, 2018

• DOI för Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
• Ladda ner fulltext (pdf) av Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers

Hammarström, Klara; Mezheyeuski, Artur; Korsavidou Hult, Nafsika; Sjöblom, Tobias et al.

Ingår i European Journal of Surgical Oncology, s. 1858-1864, 2018

• DOI för Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Kleinstern, Geffen; Camp, Nicola J.; Goldin, Lynn R.; Vachon, Celine M. et al.

Ingår i Blood, s. 2541-2551, 2018

• DOI för Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

Sclafani, Francesco; Chau, Ian; Cunningham, David; Hahne, Jens C. et al.

Ingår i Scientific Reports, 2018

• DOI för KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer

Elander, N. O.; Aughton, K.; Ghaneh, P.; Neoptolemos, J. P. et al.

Ingår i British Journal of Cancer, s. 947-954, 2018

• DOI för Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer
• Ladda ner fulltext (pdf) av Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer

Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.

Osterman, Erik; Glimelius, Bengt

Ingår i Diseases of the Colon & Rectum, s. 1016-1025, 2018

• DOI för Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.
• Ladda ner fulltext (pdf) av Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.

Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer

Mezheyeuski, Artur; Strell, Carina; Hrynchyk, Ina; Guren, Tormod Kyrre et al.

Ingår i Virchows Archiv, s. 395-405, 2018

• DOI för Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer
• Ladda ner fulltext (pdf) av Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer

Forty-five years in oncology, 25 years with Acta Oncologica

Glimelius, Bengt

Ingår i Acta Oncologica, s. 1593-1598, 2018

• DOI för Forty-five years in oncology, 25 years with Acta Oncologica

Do we make progress in elderly patients with metastatic colorectal cancer?

Glimelius, Bengt; Pfeiffer, Per

Ingår i Acta Oncologica, s. 1422-1426, 2018

• DOI för Do we make progress in elderly patients with metastatic colorectal cancer?

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

Robles-Zurita, Jose; Boyd, Kathleen A.; Briggs, Andrew H.; Iveson, Timothy et al.

Ingår i British Journal of Cancer, s. 1332-1338, 2018

• DOI för SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy

Hamfjord, J.; Guren, T.; Dajani, O.; Glimelius, Bengt et al.

Ingår i Annals of Oncology, 2018

• DOI för Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy

The PLIANT trial gives trustworthy data

Glimelius, Bengt; Kowalski, Jan; Nasstrom, Jacques

Ingår i Acta Oncologica, s. 864-866, 2018

• DOI för The PLIANT trial gives trustworthy data

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes

Wang, Sophia S.; Carrington, Mary; Berndt, Sonja I.; Slager, Susan L. et al.

Ingår i Cancer Research, s. 4086-4096, 2018

• DOI för HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Goey, Kaitlyn K. H.; Sorbye, Halfdan; Glimelius, Bengt; Adams, Richard A. et al.

Ingår i European Journal of Cancer, s. 35-45, 2018

• DOI för Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases

Cashin, Peter; Mahteme, Haile; Syk, I.; Frodin, J. E. et al.

Ingår i European Journal of Surgical Oncology, s. 983-990, 2018

• DOI för Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases

Preoperative radiotherapy or chemoradiotherapy in rectal cancer - Is survival improved?: An update of the "Nordic" LARC study in non-resectable cancers

Braendengen, Morten; Glimelius, Bengt

Ingår i Radiotherapy and Oncology, s. 392-395, 2018

• DOI för Preoperative radiotherapy or chemoradiotherapy in rectal cancer - Is survival improved?: An update of the "Nordic" LARC study in non-resectable cancers

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome

Thomsen, Maria; Skovlund, Eva; Sorbye, Halfdan; Bolstad, Nils et al.

Ingår i British Journal of Cancer, s. 1609-1616, 2018

• DOI för Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
• Ladda ner fulltext (pdf) av Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome

What treatments should be skipped or intensified in localized rectal cancer?

Glimelius, Bengt

Ingår i Future Oncology, s. 313-318, 2018

• DOI för What treatments should be skipped or intensified in localized rectal cancer?

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Iveson, Timothy J.; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim et al.

Ingår i The Lancet Oncology, s. 562-578, 2018

• DOI för 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
• Ladda ner fulltext (pdf) av 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes

Babaei, Masoud; Jansen, Lina; Balavarca, Yesilda; Sjovall, Annika et al.

Ingår i Clinical colorectal cancer, 2018

• DOI för Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes

Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy

Elander, N. O.; Aughton, K.; Ghaneh, P.; Neoptolemos, J. P. et al.

Ingår i British Journal of Cancer, s. 1084-1088, 2018

• DOI för Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy

Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based register

Chen, Lingjing; Eloranta, Sandra; Martling, Anna; Glimelius, Ingrid et al.

Ingår i Radiotherapy and Oncology, s. 424-430, 2018

• DOI för Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based register

More than 1000 new manuscripts in 2017

Glimelius, Bengt

Ingår i Acta Oncologica, s. 174-175, 2018

• DOI för More than 1000 new manuscripts in 2017

Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study

Babaei, Masoud; Balavarca, Yesilda; Jansen, Lina; Lemmens, Valery et al.

Ingår i International Journal of Cancer, s. 1480-1489, 2018

• DOI för Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study

Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells

Häggblad Sahlberg, Sara; Mortensen, Anja C.; Haglöf, Jakob; Engskog, Mikael K. R. et al.

Ingår i International Journal of Oncology, s. 5-14, 2017

• DOI för Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells
• Ladda ner fulltext (pdf) av Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells

How Relevant Is Treatment-Related Infertility for Individual Treatment Selection in Hodgkin Lymphoma?: Reply to C.F. Hess et al

Carde, Patrice P.; Grynberg, Michael; Poirot, Catherine; Glimelius, Bengt et al.

Ingår i Journal of Clinical Oncology, s. 374-374, 2017

• DOI för How Relevant Is Treatment-Related Infertility for Individual Treatment Selection in Hodgkin Lymphoma?: Reply to C.F. Hess et al

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9

Winther, Stine Braendegaard; Österlund, Pia; Berglund, Åke; Glimelius, Bengt et al.

Ingår i BMC Cancer, 2017

• DOI för Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
• Ladda ner fulltext (pdf) av Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9

Prognostic factors in patients with loco-regionally advanced gastric cancer

Hultman, Bo; Gunnarsson, Ulf; Nygren, Peter; Sundbom, Magnus et al.

Ingår i World Journal of Surgical Oncology, 2017

• DOI för Prognostic factors in patients with loco-regionally advanced gastric cancer
• Ladda ner fulltext (pdf) av Prognostic factors in patients with loco-regionally advanced gastric cancer

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

Law, Phillip J.; Berndt, Sonja I.; Speedy, Helen E.; Camp, Nicola J. et al.

Ingår i Nature Communications, 2017

• DOI för Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
• Ladda ner fulltext (pdf) av Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

Bernatsky, Sasha; Garcia, Hector A. Velasquez; Spinelli, John J.; Gaffney, Patrick et al.

Ingår i Lupus Science and Medicine, 2017

• DOI för Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer

Siesing, Christina; Sorbye, Halfdan; Dragomir, Anca; Pfeiffer, Per et al.

Ingår i PLOS ONE, 2017

• DOI för High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
• Ladda ner fulltext (pdf) av High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer

Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer

Ghanipour, Lana; Jirström, Karin; Sundström, Magnus; Glimelius, Bengt et al.

Ingår i European Journal of Surgical Oncology, s. 311-321, 2017

• DOI för Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer

Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

Mathot, Lucy; Kundu, Snehangshu; Ljungström, Viktor; Svedlund, Jessica et al.

Ingår i Cancer Research, s. 1730-1740, 2017

• DOI för Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

A pathology atlas of the human cancer transcriptome

Uhlen, Mathias; Zhang, Cheng; Lee, Sunjae; Sjöstedt, Evelina et al.

Ingår i Science, 2017

• DOI för A pathology atlas of the human cancer transcriptome

Two countries - two treatment strategies for rectal cancer

Guren, M.; Myklebust, T. A.; Lundqvist, K.; Wibe, A. et al.

Ingår i European Journal of Cancer, 2017

• DOI för Two countries - two treatment strategies for rectal cancer

Updated results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancer

Iveson, T.; Kerr, R.; Saunders, M.; Hollander, N. et al.

Ingår i Annals of Oncology, 2017

Comparison between magnetic resonance imaging (MRI) and pathology in the assessment of tumour regression grade (TRG) in rectal cancer (RC)

Sclafani, F.; Brown, G.; Cunningham, D.; Wotherspoon, A. et al.

Ingår i Annals of Oncology, 2017

COnsensus statement on Mandatory Measurements in PAncreatic Cancer Trials for systemic treatment of unresectable disease (COMMPACT)

van Rijssen, L. B.; ter Veer, E.; Besselink, M. G.; Mali, R. M. A. et al.

Ingår i Annals of Oncology, 2017

Neutrophils Predicting Tumor Local Control After Chemoradiation Therapy in Locally Advanced Pancreatic Carcinoma in the LAP 07 Trial

Schernberg, A.; Vernerey, D.; Goldstein, D.; Van Laethem, J. L. et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, 2017

What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait?

Glimelius, Bengt; Martling, A.

Ingår i Acta Oncologica, s. 1139-1142, 2017

• DOI för What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait?

Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer

Sclafani, Francesco; Brown, Gina; Cunningham, David; Wotherspoon, Andrew et al.

Ingår i British Journal of Cancer, s. 1478-1485, 2017

• DOI för Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer

Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status

Thomsen, Maria; Guren, Marianne Gronlie; Skovlund, Eva; Glimelius, Bengt et al.

Ingår i European Journal of Cancer, s. 26-35, 2017

• DOI för Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

Neoptolemos, John P.; Palmer, Daniel H.; Ghaneh, Paula; Psarelli, Eftychia E. et al.

Ingår i The Lancet, s. 1011-1024, 2017

• DOI för Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
• Ladda ner fulltext (pdf) av Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

Risk of second primary cancer in patients treated with radiotherapy for rectal cancer

Martling, A.; Smedby, K. E.; Birgisson, Helgi; Olsson, H. et al.

Ingår i British Journal of Surgery, s. 278-287, 2017

• DOI för Risk of second primary cancer in patients treated with radiotherapy for rectal cancer

Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial

Erlandsson, Johan; Holm, Torbjörn; Pettersson, David; Berglund, Åke et al.

Ingår i The Lancet Oncology, s. 336-346, 2017

• DOI för Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial

Need for adjuvant chemotherapy after colon cancer surgery - has it decreased?

Boeckelman, Camilla; Glimelius, Bengt

Ingår i Acta Oncologica, s. 629-633, 2017

• DOI för Need for adjuvant chemotherapy after colon cancer surgery - has it decreased?

Development of anxiety, depression and health-related quality of life in oncology patients without initial symptoms according to the Hospital Anxiety and Depression Scale – a comparative study

Thalén Lindström, Annika; Glimelius, Bengt; Johansson, Birgitta

Ingår i Acta Oncologica, s. 1094-1102, 2017

• DOI för Development of anxiety, depression and health-related quality of life in oncology patients without initial symptoms according to the Hospital Anxiety and Depression Scale – a comparative study

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study

Guren, Tormod Kyrre; Thomsen, Maria; Kure, Elin H.; Sorbye, Halfdan et al.

Ingår i British Journal of Cancer, s. 1271-1278, 2017

• DOI för Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
• Ladda ner fulltext (pdf) av Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study

ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma

Neoptolemos, J. P.; Palmer, D.; Ghaneh, P.; Valle, J. et al.

Ingår i Pancreas, s. 1529-1529, 2016

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

Machiela, Mitchell J.; Lan, Qing; Slager, Susan L.; Vermeulen, Roel C. H. et al.

Ingår i Human Molecular Genetics, s. 1663-1676, 2016

• DOI för Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer

Tarpgaard, Line S.; Orum-Madsen, Maj Sofie; Christensen, Ib J.; Nordgaard, Cathrine et al.

Ingår i Oncotarget, s. 59441-59457, 2016

• DOI för TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer

Mezheyeuski, Artur; Lindh, Maja Bradic; Guren, Tormod Kyrre; Dragomir, Anca et al.

Ingår i Oncotarget, s. 41948-41958, 2016

• DOI för Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

Thomsen, Maria; Kersten, Christian; Sorbye, Halfdan; Skovlund, Eva et al.

Ingår i Oncotarget, s. 75013-75022, 2016

• DOI för Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

Berndt, Sonja I.; Camp, Nicola J.; Skibola, Christine F.; Vijai, Joseph et al.

Ingår i Nature Communications, 2016

• DOI för Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
• Ladda ner fulltext (pdf) av Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer

Mezheyeuski, Artur; Hrynchyk, Ina; Karlberg, Mia; Portyanko, Anna et al.

Ingår i Scientific Reports, 2016

• DOI för Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer
• Ladda ner fulltext (pdf) av Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer

Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry

Nikberg, Maziar; Chabok, Abbas; Letocha, Henry; Kindler, Csaba et al.

Ingår i Acta Oncologica, s. 1418-1424, 2016

• DOI för Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry

Detection of prognostic biomarkers with solid-phase proximity ligation assay in patients with colorectal cancer

Ghanipour, Lana; Darmanis, Spyros; Landegren, Ulf; Glimelius, Bengt et al.

Ingår i Translational Oncology, s. 251-255, 2016

• DOI för Detection of prognostic biomarkers with solid-phase proximity ligation assay in patients with colorectal cancer
• Ladda ner fulltext (pdf) av Detection of prognostic biomarkers with solid-phase proximity ligation assay in patients with colorectal cancer

Identification of distress in oncology patients: a comparison of the Hospital Anxiety and Depression Scale and a thorough clinical assessment

Thalén-Lindström, Annika; Glimelius, Bengt; Johansson, Birgitta

Ingår i Cancer Nursing, 2016

• DOI för Identification of distress in oncology patients: a comparison of the Hospital Anxiety and Depression Scale and a thorough clinical assessment

Does shared decision making exist in oncologic practice?

Glimelius, Bengt; Cavalli-Björkman, Nina

Ingår i Acta Oncologica, s. 125-128, 2016

• DOI för Does shared decision making exist in oncologic practice?

Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial

Cashin, Peter H.; Mahteme, Haile; Spang, N.; Syk, I. et al.

Ingår i European Journal of Cancer, s. 155-162, 2016

• DOI för Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial

Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer

Elliot, A. H.; Martling, A.; Glimelius, Bengt; Johansson, H. et al.

Ingår i European Journal of Surgical Oncology, s. 1667-1673, 2016

• DOI för Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer

Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer Reply

Glimelius, Bengt; Hohenberger, Werner Max; Matzel, Klaus E.; Sugihara, Kenichi et al.

Ingår i Journal of Clinical Oncology, s. 3713-+, 2016

• DOI för Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer Reply

Two countries - Two treatment strategies for rectal cancer

Glimelius, Bengt; Myklebust, Tor Åge; Lundqvist, Kristina; Wibe, Arne et al.

Ingår i Radiotherapy and Oncology, s. 357-363, 2016

• DOI för Two countries - Two treatment strategies for rectal cancer

What is most relevant in preoperative rectal cancer chemoradiotherapy - the chemotherapy, the radiation dose or the timing to surgery?

Glimelius, Bengt

Ingår i Acta Oncologica, s. 1381-1385, 2016

• DOI för What is most relevant in preoperative rectal cancer chemoradiotherapy - the chemotherapy, the radiation dose or the timing to surgery?

KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial

Sclafani, F.; Chau, I.; Cunningham, D.; Vlachogiannis, G. et al.

Ingår i Annals of Oncology, 2016

• DOI för KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial

PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer

Sclafani, F.; Brown, G.; Cunningham, D.; Wotherspoon, A. et al.

Ingår i Annals of Oncology, s. 1557-1565, 2016

• DOI för PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer

NORDIC9: A randomized phase II trial exploring treatment of older patients with metastatic colorectal cancer (mCRC) by comparing full dose monotherapy (S-1 followed by irinotecan) with reduced combination regimen (S-1/oxaliplatin followed by S-1/irinotecan)

Winther, S. B.; Osterlund, P.; Berglund, Åke; Glimelius, Bengt et al.

Ingår i Annals of Oncology, 2016

• DOI för NORDIC9: A randomized phase II trial exploring treatment of older patients with metastatic colorectal cancer (mCRC) by comparing full dose monotherapy (S-1 followed by irinotecan) with reduced combination regimen (S-1/oxaliplatin followed by S-1/irinotecan)

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients

Sclafani, Francesco; Chau, Ian; Cunningham, David; Lampis, Andrea et al.

Ingår i Carcinogenesis, s. 852-857, 2016

• DOI för Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients

Tell all the good news as soon as possible

Glimelius, Bengt

Ingår i Acta Oncologica, s. 1067-1068, 2016

• DOI för Tell all the good news as soon as possible

Any progress in pancreatic cancer?

Glimelius, Bengt

Ingår i Acta Oncologica, s. 255-258, 2016

• DOI för Any progress in pancreatic cancer?

Eight Cycles of ABVD Versus Four Cycles of BEACOPP(escalated) Plus Four Cycles of BEACOPP(baseline) in Stage III to IV, International Prognostic Score >= 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial

Carde, Patrice; Karrasch, Matthias; Fortpied, Catherine; Brice, Pauline et al.

Ingår i Journal of Clinical Oncology, s. 2028-+, 2016

• DOI för Eight Cycles of ABVD Versus Four Cycles of BEACOPP(escalated) Plus Four Cycles of BEACOPP(baseline) in Stage III to IV, International Prognostic Score >= 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial

Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?

Påhlman, Lars A.; Hohenberger, Werner M.; Matzel, Klaus; Sugihara, Kenichi et al.

Ingår i Journal of Clinical Oncology, s. 1297-+, 2016

• DOI för Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

Hammel, Pascal; Huguet, Florence; van Laethem, Jean-Luc; Goldstein, David et al.

Ingår i Journal of the American Medical Association (JAMA), s. 1844-1853, 2016

• DOI för Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)

Vernerey, Dewi; Huguet, Florence; Vienot, Angelique; Goldstein, David et al.

Ingår i British Journal of Cancer, s. 281-289, 2016

• DOI för Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)

Healthcare Use Among Young Hodgkin Lymphoma Survivors In The Era Of Intensified Chemotherapy And Limited Radiotherapy

Eloranta, S.; Smedby, K. E.; Ekberg, S.; Chang, E. et al.

Ingår i Haematologica, s. 64-65, 2016

Hodgkin Lymphoma In Children, Adolescents And Young Adults-A Comparative Study Of Clinical Presentation And Treatment Outcome

Englund, Annika; Glimelius, Bengt; Rostgaard, K.; Eloranta, S. et al.

Ingår i Haematologica, s. 36-36, 2016

Potential value of immunoscoring in rectal cancer patients

Glimelius, Bengt

Ingår i TRANSLATIONAL CANCER RESEARCH, s. 94-97, 2016

• DOI för Potential value of immunoscoring in rectal cancer patients

Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma

Hollander, Peter; Rostgaard, Klaus; Smedby, Karin E.; Chang, Ellen T. et al.

Ingår i American Journal of Epidemiology, s. 624-632, 2015

• DOI för Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

Birgisson, Helgi; Edlund, Karolina; Wallin, Ulrik; Påhlman, Lars et al.

Ingår i BMC Cancer, 2015

• DOI för Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer
• Ladda ner fulltext (pdf) av Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

Vijai, Joseph; Wang, Zhaoming; Berndt, Sonja I.; Skibola, Christine F. et al.

Ingår i Nature Communications, 2015

• DOI för A genome-wide association study of marginal zone lymphoma shows association to the HLA region
• Ladda ner fulltext (pdf) av A genome-wide association study of marginal zone lymphoma shows association to the HLA region

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort

Sorbye, Halfdan; Dragomir, Anca; Sundström, Magnus; Pfeiffer, Per et al.

Ingår i PLOS ONE, 2015

• DOI för High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort

Tumour regression in the randomized Stockholm III Trial ofradiotherapy regimens for rectal cancer

Pettersson, D.; Loerinc, E.; Holm, T.; Iversen, H. et al.

Ingår i British Journal of Surgery, s. 972-978, 2015

• DOI för Tumour regression in the randomized Stockholm III Trial ofradiotherapy regimens for rectal cancer
• Ladda ner fulltext (pdf) av Tumour regression in the randomized Stockholm III Trial ofradiotherapy regimens for rectal cancer

Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?

Dueland, Svein; Guren, Tormod K.; Hagness, Morten; Glimelius, Bengt et al.

Ingår i Annals of Surgery, s. 956-960, 2015

• DOI för Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

Breugom, A. J.; van Gijn, W.; Muller, E. W.; Berglund, Åke et al.

Ingår i Annals of Oncology, s. 696-701, 2015

• DOI för Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

A template for writing radiotherapy protocols

Nilsson, Per; Ceberg, Crister; Kjellen, Elisabeth; Gagliardi, Giovanna et al.

Ingår i Acta Oncologica, s. 275-279, 2015

• DOI för A template for writing radiotherapy protocols

Prognostic effect of a single nucleotide polymorphism (SNP) in MIR608 in patients with high-risk locally advanced rectal cancer (LARC): Results of the EXPERT-C trial.

Sclafani, Francesco; Chau, Ian; Cunningham, David; Lampis, Andrea et al.

Ingår i Journal of Clinical Oncology, 2015

Prognosis model for overall survival in locally advanced unresecable pancreatic carcinoma: An ancillary study of the LAP 07 trial

Vernerey, Dewi; Hammel, Pascal; Paget-Bailly, Sophie; Huguet, Florence et al.

Ingår i Journal of Clinical Oncology, 2015

The evolution of radiotherapy techniques in the management of prostate cancer

Hoyer, Morten; Muren, Ludvig P.; Glimelius, Bengt

Ingår i Acta Oncologica, s. 821-824, 2015

• DOI för The evolution of radiotherapy techniques in the management of prostate cancer

Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery +/- a fluoropyrimidine and surgery plus a fluoropyrimidine +/- oxaliplatin

Bujko, K.; Glimelius, Bengt; Valentini, V.; Michalski, W. et al.

Ingår i European Journal of Surgical Oncology, s. 713-723, 2015

• DOI för Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery +/- a fluoropyrimidine and surgery plus a fluoropyrimidine +/- oxaliplatin

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

Glimelius, Bengt

Ingår i Acta Oncologica, s. 433-436, 2015

• DOI för Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group

Pfeiffer, Per; Sorbye, Hafdan; Qvortrup, Camilla; Karlberg, Mia et al.

Ingår i Clinical colorectal cancer, s. 170-176, 2015

• DOI för Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group

Time trends, improvements and national auditing of rectal cancer management over an 18-year period

Kodeda, K.; Johansson, R.; Zar, N.; Birgisson, Helgi et al.

Ingår i Colorectal Disease, 2015

• DOI för Time trends, improvements and national auditing of rectal cancer management over an 18-year period

C-reactive protein and interleukin-6 as markers of systemic inflammatory response and as prognostic factors for metastatic colorectal cancer. Data from the randomized phase III NORDIC-VII study

Thomsen, Maria; Kersten, Christian; Sorbye, Halfdan; Skovlund, Eva et al.

Ingår i Journal of Clinical Oncology, 2015

Is the benefit of oxaliplatin in rectal cancer clinically relevant?

Glimelius, Bengt

Ingår i The Lancet Oncology, s. 883-885, 2015

• DOI för Is the benefit of oxaliplatin in rectal cancer clinically relevant?

Toxicity and quality of life data from SCOT: An international phase III randomized (1:1) noninferiority trial comparing 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy.

Iveson, Timothy; Kerr, Rachel; Saunders, Mark P.; Waterston, Ashita Marie et al.

Ingår i Journal of Clinical Oncology, 2015

Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab

Tarpgaard, Line S.; Christensen, Ib J.; Hoyer-Hansen, Gunilla; Lund, Ida K. et al.

Ingår i International Journal of Cancer, s. 2470-2477, 2015

• DOI för Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial

Sclafani, F.; Chau, I.; Cunningham, D.; Peckitt, C. et al.

Ingår i Annals of Oncology, s. 1936-1941, 2015

• DOI för Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial
• Ladda ner fulltext (pdf) av Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial

Is England closing the international gap in cancer survival?

Walters, Sarah; Benitez-Majano, Sara; Muller, Patrick; Coleman, Michel P. et al.

Ingår i British Journal of Cancer, s. 848-860, 2015

• DOI för Is England closing the international gap in cancer survival?
• Ladda ner fulltext (pdf) av Is England closing the international gap in cancer survival?

Short-and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial

Sclafani, Francesco; Peckitt, Clare; Cunningham, David; Tait, Diana et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, s. 303-312, 2015

• DOI för Short-and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial

Prognostic role of the LCS-6 KRAS variant in locally advanced rectal cancer: Results of the EXPERT-C trial

Sclafani, F.; Chau, I.; Cunningham, D.; Peckitt, C. et al.

Ingår i European Journal of Cancer, 2015

What's new about Acta Oncologica for 2016?

Glimelius, Bengt

Ingår i Acta Oncologica, s. 1703-1705, 2015

• DOI för What's new about Acta Oncologica for 2016?

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

Sampson, Joshua N.; Wheeler, William A.; Yeager, Meredith; Panagiotou, Orestis et al.

Ingår i Journal of the National Cancer Institute, 2015

• DOI för Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

O-15-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases

Lubberink, Mark; Golla, Sanjeep S. V.; Jonasson, My; Rubin, Kristofer et al.

Ingår i Journal of Nuclear Medicine, s. 1144-1149, 2015

• DOI för O-15-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

Cerhan, James R.; Berndt, Sonja I.; Vijai, Joseph; Ghesquieres, Herve et al.

Ingår i Nature Genetics, s. 1233-1238, 2014

• DOI för Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

Skibola, Christine F.; Berndt, Sonja I.; Vijai, Joseph; Conde, Lucia et al.

Ingår i American Journal of Human Genetics, s. 462-471, 2014

• DOI för Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

Cozen, W.; Timofeeva, M. N.; Li, D.; Diepstra, A. et al.

Ingår i Nature Communications, s. 3856, 2014

• DOI för A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

Mayrhofer, Markus; Kultima, Hanna Göransson; Birgisson, Helgi; Sundström, Magnus et al.

Ingår i BMC Cancer, s. 872, 2014

• DOI för 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
• Ladda ner fulltext (pdf) av 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer

Lindskog, Elinor Bexe; Gunnarsdottir, Katrin Asta; Derwinger, Kristoffer; Wettergren, Yvonne et al.

Ingår i BMC Cancer, s. 948, 2014

• DOI för A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer
• Ladda ner fulltext (pdf) av A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer

A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival

Baecklund, Fredrik; Foo, Jia-Nee; Bracci, Paige; Darabi, Hatef et al.

Ingår i BMC Medical Genetics, s. 113, 2014

• DOI för A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival
• Ladda ner fulltext (pdf) av A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival

Comparison of two instruments for measurement of quality of life in clinical practice - a qualitative study

Wettergren, Lena; Lindberg, Mathilde Hedlund; Kettis, Åsa; Glimelius, Bengt et al.

Ingår i BMC Medical Research Methodology, s. 115, 2014

• DOI för Comparison of two instruments for measurement of quality of life in clinical practice - a qualitative study
• Ladda ner fulltext (pdf) av Comparison of two instruments for measurement of quality of life in clinical practice - a qualitative study

Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

Rosmarin, Dan; Palles, Claire; Church, David; Domingo, Enric et al.

Ingår i Journal of Clinical Oncology, s. 1031-1039, 2014

• DOI för Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study

Tarpgaard, Line S.; Guren, Tormod K.; Glimelius, Bengt; Christensen, Ib J. et al.

Ingår i PLOS ONE, 2014

• DOI för Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study
• Ladda ner fulltext (pdf) av Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study

Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.

Häggblad Sahlberg, Sara; Spiegelberg, Diana; Glimelius, Bengt; Stenerlöw, Bo et al.

Ingår i PLOS ONE, 2014

• DOI för Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
• Ladda ner fulltext (pdf) av Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.

Clinical Benefit Response in Pancreatic Cancer Trials Revisited

Bernhard, Juerg; Dietrich, Daniel; Glimelius, Bengt; Bodoky, Gyoergy et al.

Ingår i Oncology Research and Treatment, s. 42-48, 2014

• DOI för Clinical Benefit Response in Pancreatic Cancer Trials Revisited

Cost-utility analysis of individual psychosocial support interventions for breast cancer patients in a randomized controlled study

Arving, Cecilia; Brandberg, Yvonne; Feldman, Inna; Johansson, Birgitta et al.

Ingår i Psycho-Oncology, s. 251-258, 2014

• DOI för Cost-utility analysis of individual psychosocial support interventions for breast cancer patients in a randomized controlled study

The 50-year anniversary of Acta Oncologica

Glimelius, Bengt

Ingår i Acta Oncologica, s. 1-2, 2014

• DOI för The 50-year anniversary of Acta Oncologica

EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

van de Velde, Cornelis J. H.; Boelens, Petra G.; Borras, Josep M.; Coebergh, Jan-Willem et al.

Ingår i European Journal of Cancer, 2014

• DOI för EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines

Häggblad Sahlberg, Sara; Gustafsson, Ann-Sofie; Pendekanti, Prathyusha N.; Glimelius, Bengt et al.

Ingår i Tumor Biology, s. 3525-3534, 2014

• DOI för The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines
• Ladda ner fulltext (pdf) av The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines

Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

Greenhalf, William; Ghaneh, Paula; Neoptolemos, John P.; Palmer, Daniel H. et al.

Ingår i Journal of the National Cancer Institute, 2014

• DOI för Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

Adjuvant chemotherapy for rectal cancer still controversial

Beets, Geerard L.; Glimelius, Bengt

Ingår i The Lancet Oncology, s. 130-131, 2014

• DOI för Adjuvant chemotherapy for rectal cancer still controversial

TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial

Sclafani, Francesco; Gonzalez, David; Cunningham, David; Wilson, Sanna Hulkki et al.

Ingår i Journal of the National Cancer Institute, 2014

• DOI för TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial

Fc gamma RIIa and Fc gamma RIIIa Polymorphisms and Cetuximab Benefit in the Microscopic Disease

Sclafani, Francesco; de Castro, David Gonzalez; Cunningham, David; Wilson, Sanna Hulkki et al.

Ingår i Clinical Cancer Research, s. 4511-4519, 2014

• DOI för Fc gamma RIIa and Fc gamma RIIIa Polymorphisms and Cetuximab Benefit in the Microscopic Disease

Liver Transplantation or Chemotherapy for Non-Resectable Colorectal Liver Metastases?

Hagness, M.; Guren, T.; Glimelius, Bengt; Pfeiffer, P. et al.

Ingår i Transplantation, s. 166-166, 2014

Liver Transplantation or Chemotherapy for Non-Resectable Colorectal Liver Metastases?

Hagness, M.; Guren, T.; Glimelius, Bengt; Pfeiffer, P. et al.

Ingår i American Journal of Transplantation, s. 166-166, 2014

The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis

Dias, M M; Pignon, J-P; Karapetis, C S; Boige, V et al.

Ingår i The Pharmacogenomics Journal, s. 424-431, 2014

• DOI för The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis

Acta Oncologica and a new generation of scientists in oncology

Glimelius, Bengt; Johansen, Christoffer; Muren, Ludvig Paul; Nilbert, Mef

Ingår i Acta Oncologica, s. 849-851, 2014

• DOI för Acta Oncologica and a new generation of scientists in oncology

RAS mutations and cetuximab in locally advanced rectal cancer: Results of the EXPERT-C trial

Sclafani, F.; Gonzalez, D.; Cunningham, D.; Wilson, S. Hulkki et al.

Ingår i European Journal of Cancer, s. 1430-1436, 2014

• DOI för RAS mutations and cetuximab in locally advanced rectal cancer: Results of the EXPERT-C trial

Outcome after liver transplantation compared with chemotherapy in colorectal cancer patients with nonresectable liver-only disease.

Dueland, Svein; Kyrre, Tormod; Hagness, Guren Morten; Glimelius, Bengt et al.

Ingår i Journal of Clinical Oncology, 2014

Relationship of RAS and TP53 predictive value for cetuximab (C) benefit: Results of the EXPERT-C trial

Sclafani, Francesco; Gonzalez, David; Cunningham, David; Wilson, Sanna Hullki et al.

Ingår i Journal of Clinical Oncology, 2014

RAS mutations in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab (C) in MRI-defined, high-risk rectal cancer (RC).

Sclafani, Francesco; Gonzalez, David; Cunningham, David; Wilson, Sanna Hullki et al.

Ingår i Journal of Clinical Oncology, 2014

Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial

Salazar, Ramon; Capdevila, Jaume; Rosenberg, Robert; de Waard, Jan Willem et al.

Ingår i Journal of Clinical Oncology, 2014

Adjuvant chemotherapy for rectal cancer

Bujko, Krzysztof; Glimelius, Bengt

Ingår i The Lancet Oncology, 2014

• DOI för Adjuvant chemotherapy for rectal cancer

Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin)

Gubanski, M.; Glimelius, Bengt; Lind, P. A.

Ingår i Medical Oncology, s. 906, 2014

• DOI för Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin)

Preoperative treatment selection in rectal cancer: A population-based cohort study

Elliot, A. H.; Martling, A.; Glimelius, Bengt; Nordenvall, C. et al.

Ingår i European Journal of Surgical Oncology, s. 1782-1788, 2014

• DOI för Preoperative treatment selection in rectal cancer: A population-based cohort study

QOL assessments in clinical practice: usefulness of ERORTC-QLQC-30 and the SEIOQL

Ring, Lena; Wettergren, Lena; Fagerlind, Hanna; Glimelius, Bengt et al.

Ingår i Quality of Life Research, s. 104-104, 2014

Benefit of EGFR-inhibition therapy for metastatic colorectal cancer patients with KRAS-mutated tumors and high plasma TIMP-I level: Results from the NORDIC VII study

Brunner, Nils; Tarpgaard, Line Schmidt; Christensen, Ib Jarle; Moreira, Jose et al.

Ingår i Journal of Clinical Oncology, 2014

FC gamma RIIa and FC gamma RIIa polymorphisms (SNPs) and cetuximab (C) benefit in the EXPERT-C trial

Sclafani, Francesco; Gonzalez de Castro, David; Cunningham, David; Wilson, Sanna Hulkki et al.

Ingår i Journal of Clinical Oncology, 2014

Digitalized multiparametric analyses of tumor stroma for identification of low perivascular PDGFBR expression and low vessel density as independent prognosis markers for stage IV CRC

Mezheyeuski, Artur; Lindh, Maja Bradic; Glimelius, Bengt; Pfeiffer, Per et al.

Ingår i Journal of Clinical Oncology, 2014

Panex: A pooled analysis of EXPERT and EXPERT-C, two trials of neoadjuvant chemotherapy (NACT) and chemoradiotherapy (CRT) in high-risk locally advanced rectal cancer (LARC)

Sclafani, Francesco; Peckitt, Clare; Cunningham, David; Evans, Jessica et al.

Ingår i Journal of Clinical Oncology, 2014

Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial

Salazar, Ramon; Capdevila, Jaume; Rosenberg, Robert; Glimelius, Bengt et al.

Ingår i Journal of Clinical Oncology, 2014

Barriers against psychosocial communication: Oncologists' perceptions

Fagerlind, Hanna; Kettis, Åsa; Glimelius, Bengt; Ring, Lena

Ingår i Journal of Clinical Oncology, 2013

• DOI för Barriers against psychosocial communication: Oncologists' perceptions

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial

Nilsson, Per J.; van Etten, Boudewijn; Hospers, Geke A. P.; Påhlman, Lars et al.

Ingår i BMC Cancer, s. 279, 2013

• DOI för Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial
• Ladda ner fulltext (pdf) av Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial

Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study

Tiselius, C; Gunnarsson, U; Smedh, Kennet; Glimelius, Bengt et al.

Ingår i Annals of Oncology, s. 160-165, 2013

• DOI för Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study

Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy

Hultman, Bo; Lind, Pehr; Glimelius, Bengt; Sundbom, Magnus et al.

Ingår i Acta Oncologica, s. 824-830, 2013

• DOI för Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy

Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients

Radu, Calin; Norrlid, Ola; Braendengen, Morten; Hansson, Karl et al.

Ingår i Acta Oncologica, s. 528-537, 2013

• DOI för Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients

Anxiety and depression in oncology patients: a longitudinal study of a screening, assessment and psychosocial support intervention

Thalén-Lindström, Annika; Larsson, Gunnel; Glimelius, Bengt; Johansson, Birgitta

Ingår i Acta Oncologica, s. 118-127, 2013

• DOI för Anxiety and depression in oncology patients: a longitudinal study of a screening, assessment and psychosocial support intervention

Validation of the Distress Thermometer in a Swedish population of oncology patients: accuracy of changes during six months

Thalén-Lindström, Annika; Larsson, Gunnel; Hellbom, Maria; Glimelius, Bengt et al.

Ingår i European Journal of Oncology Nursing, s. 625-631, 2013

• DOI för Validation of the Distress Thermometer in a Swedish population of oncology patients: accuracy of changes during six months

Neo-adjuvant radiotherapy in rectal cancer

Glimelius, Bengt

Ingår i World Journal of Gastroenterology, s. 8489-8501, 2013

• DOI för Neo-adjuvant radiotherapy in rectal cancer

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

Sclafani, F.; Roy, A.; Cunningham, D.; Wotherspoon, A. et al.

Ingår i Annals of Oncology, s. 3123-3128, 2013

• DOI för HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

Berndt, Sonja I.; Skibola, Christine F.; Joseph, Vijai; Camp, Nicola J. et al.

Ingår i Nature Genetics, s. 868-U202, 2013

• DOI för Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

Coding Variants at Hexa-allelic Amino Acid 13 of HLA-DRB1 Explain Independent SNP Associations with Follicular Lymphoma Risk

Foo, Jia Nee; Smedby, Karin E.; Akers, Nicholas K.; Berglund, Mattias et al.

Ingår i American Journal of Human Genetics, s. 167-172, 2013

• DOI för Coding Variants at Hexa-allelic Amino Acid 13 of HLA-DRB1 Explain Independent SNP Associations with Follicular Lymphoma Risk

Population-based data from the Swedish Colon Cancer Registry

Kodeda, K.; Nathanaelsson, L.; Jung, B.; Olsson, H. et al.

Ingår i British Journal of Surgery, s. 1100-1107, 2013

• DOI för Population-based data from the Swedish Colon Cancer Registry

Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy

Suzuki, Chikako; Blomqvist, Lennart; Hatschek, Thomas; Carlsson, Lena et al.

Ingår i Medical Oncology, s. 415, 2013

• DOI för Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy

Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes

Simard, Julia F; Baecklund, Fredrik; Chang, Ellen T; Baecklund, Eva et al.

Ingår i International Journal of Cancer, s. 2659-2666, 2013

• DOI för Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes

Establishing and expanding the indications for proton and particle therapy

Muren, Ludvig P.; Rossi, Carl; Hug, Eugen; Lee, Andrew et al.

Ingår i Acta Oncologica, s. 459-462, 2013

• DOI för Establishing and expanding the indications for proton and particle therapy

50 years with Acta Oncologica

Glimelius, Bengt

Ingår i Acta Oncologica, s. 1-2, 2013

• DOI för 50 years with Acta Oncologica

Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial

Pettersson, D.; Glimelius, Bengt; Iversen, H.; Johansson, H. et al.

Ingår i British Journal of Surgery, s. 969-U145, 2013

• DOI för Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial

The rise and fall of a longed for clinical trial in patients with generalized colorectal cancer

Arbman, Gunnar; Påhlman, Lars; Glimelius, Bengt

Ingår i Acta Oncologica, s. 1779-1782, 2013

• DOI för The rise and fall of a longed for clinical trial in patients with generalized colorectal cancer

What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

Steineck, Gunnar; Glimelius, Bengt

Ingår i Acta Oncologica, s. 1589-1592, 2013

• DOI för What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Glimelius, Bengt; Tiret, E.; Cervantes, A.; Arnold, D.

Ingår i Annals of Oncology, s. 81-88, 2013

• DOI för Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Radiotherapy in rectal cancer - What have we learnt?

Glimelius, Bengt

Ingår i European Journal of Cancer, 2013

Updated survival analysis of EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab in MRI-defined high risk rectal cancer patients

Sclafani, F.; Cunningham, D.; Tabernero, J.; Glimelius, Bengt et al.

Ingår i European Journal of Cancer, 2013

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Nordlinger, Bernard; Sorbye, Halfdan; Glimelius, Bengt; Poston, Graeme J. et al.

Ingår i The Lancet Oncology, s. 1208-1215, 2013

• DOI för Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Investigation of Relation of Radiation Therapy Quality Assurance Scores (RTQASc) With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma (LAPC)

Huguet, F.; Racadot, S.; Goldstein, D.; Spry, N. et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, 2013

Potentials of high resolution magnetic resonance imaging versus computed tomography for preoperative local staging of colon cancer

Rollven, Erik; Holm, Torbjorn; Glimelius, Bengt; Lorinc, Esther et al.

Ingår i Acta Radiologica, s. 722-730, 2013

• DOI för Potentials of high resolution magnetic resonance imaging versus computed tomography for preoperative local staging of colon cancer

Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer

Sorbye, H.; Cvancarova, M.; Qvortrup, C.; Pfeiffer, P. et al.

Ingår i Annals of Oncology, s. 2354-2360, 2013

• DOI för Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer

Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study

Hammel, Pascal; Huguet, Florence; Van Laethem, Jean-Luc; Goldstein, David et al.

Ingår i Journal of Clinical Oncology, 2013

EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in Europe

van de Velde, Cornelis J. H.; Aristei, Cynthia; Boelens, Petra G.; Beets-Tan, Regina G. H. et al.

Ingår i European Journal of Cancer, s. 2784-2790, 2013

• DOI för EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in Europe

Let-7 miRNA-binding site polymorphism in the KRAS 3`UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.

Kjersem, Janne B; Ikdahl, Tone; Guren, Tormod; Skovlund, Eva et al.

Ingår i BMC Cancer, s. 534, 2012

• DOI för Let-7 miRNA-binding site polymorphism in the KRAS 3`UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.
• Ladda ner fulltext (pdf) av Let-7 miRNA-binding site polymorphism in the KRAS 3`UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.

Quality of life in peritoneal carcinomatosis after cytoreductive surgery and intraperitoneal chemotherapy

Hansson, Johan; Graf, Wilhelm; Nygren, Peter; Ring, Lena et al.

2012

Equal cancer treatment regardless of education level and family support?: A qualitative study of oncologists’ decision-making

Cavalli-Björkman, Nina; Glimelius, Bengt; Strang, Peter

Ingår i BMJ Open, 2012

• DOI för Equal cancer treatment regardless of education level and family support?: A qualitative study of oncologists’ decision-making

The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines

Häggblad Sahlberg, Sara; Spiegelberg, Diana; Lennartsson, Johan; Nygren, Peter et al.

Ingår i International Journal of Oncology, s. 176-184, 2012

• DOI för The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines
• Ladda ner fulltext (pdf) av The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines

Histopathological Classification of Pseudomyxoma Peritonei and the Prognostic Importance of PINCH Protein

Andreasson, Håkan; Wanders, Alkwin; Sun, Xiao-Feng; Willén, Roger et al.

Ingår i Anticancer Research, s. 1443-1448, 2012

Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer

Hultman, Bo; Lundkvist, Jonas; Glimelius, Bengt; Nygren, Peter et al.

Ingår i Acta Oncologica, s. 112-121, 2012

• DOI för Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer

Outcome differences between debulking surgery and cytoreductive surgery in patients with pseudomyxoma peritonei

Andréasson, Håkan; Graf, Wilhelm; Nygren, Peter; Glimelius, Bengt et al.

Ingår i European Journal of Surgical Oncology, s. 962-968, 2012

• DOI för Outcome differences between debulking surgery and cytoreductive surgery in patients with pseudomyxoma peritonei

Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups

Urayama, Kevin Y.; Jarrett, Ruth F.; Hjalgrim, Henrik; Diepstra, Arjan et al.

Ingår i Journal of the National Cancer Institute, s. 240-253, 2012

• DOI för Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups

The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy

Suzuki, C; Blomqvist, L; Sundin, Anders; Jacobsson, H et al.

Ingår i Annals of Oncology, s. 948-954, 2012

• DOI för The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy

Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer: Long-term results from a phase III study

Brændengen, Morten; Tveit, Kjell M; Hjermstad, Marianne J; Johansson, Hemming et al.

Ingår i European Journal of Cancer, s. 813-819, 2012

• DOI för Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer: Long-term results from a phase III study

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

Sorbye, Halfdan; Mauer, Murielle; Gruenberger, Thomas; Glimelius, Bengt et al.

Ingår i Annals of Surgery, s. 534-539, 2012

• DOI för Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone

Cavalli-Björkman, Nina; Qvortrup, Camilla; Sebjørnssen, Sigrunn; Pfeiffer, Per et al.

Ingår i British Journal of Cancer, s. 189-194, 2012

• DOI för Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone

Metastatic colorectal cancer: Current treatment and future options for improved survival : Medical approach - present status

Glimelius, Bengt; Cavalli-Bjorkman, Nina

Ingår i Scandinavian Journal of Gastroenterology, s. 296-314, 2012

• DOI för Metastatic colorectal cancer: Current treatment and future options for improved survival : Medical approach - present status

Quantitative accuracy of parametric myocardial and tumour blood flow images based on HYPR-LR-filtered dynamic [O-15]water PET

Golla, Sandeep; Sörensen, Jens; Kero, Tanja; Harms, H. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2012

Intrapatient Cetuximab Dose Escalation in Metastatic Colorectal Cancer According to the Grade of Early Skin Reactions: The Randomized EVEREST Study

Van Cutsem, Eric; Tejpar, Sabine; Vanbeckevoort, Dirk; Peeters, Marc et al.

Ingår i Journal of Clinical Oncology, s. 2861-2868, 2012

• DOI för Intrapatient Cetuximab Dose Escalation in Metastatic Colorectal Cancer According to the Grade of Early Skin Reactions: The Randomized EVEREST Study

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Tveit, Kjell Magne; Guren, Tormod; Glimelius, Bengt; Pfeiffer, Per et al.

Ingår i Journal of Clinical Oncology, s. 1755-1762, 2012

• DOI för Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Different perspectives on communication quality and emotional functioning during routine oncology consultations

Fagerlind, Hanna; Kettis, Åsa; Bergström, Ida; Glimelius, Bengt et al.

Ingår i Patient Education and Counseling, s. 16-22, 2012

• DOI för Different perspectives on communication quality and emotional functioning during routine oncology consultations

Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future

Glimelius, Bengt

Ingår i Upsala Journal of Medical Sciences, s. 225-236, 2012

• DOI för Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial

Neoptolemos, John P.; Moore, Malcolm J.; Cox, Trevor F.; Valle, Juan W. et al.

Ingår i Journal of the American Medical Association (JAMA), s. 147-156, 2012

• DOI för Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Dewdney, Alice; Cunningham, David; Tabernero, Josep; Capdevila, Jaume et al.

Ingår i Journal of Clinical Oncology, s. 1620-1627, 2012

• DOI för Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Long term survival data from EORTC study 40983: Perioperative chemotherapy for resectable liver metastases from colorectal cancer

Nordlinger, Bernard; Sorbye, Halfdan; Glimelius, Bengt; Poston, Graeme John et al.

Ingår i Annals of Oncology, s. 18-18, 2012

• DOI för Long term survival data from EORTC study 40983: Perioperative chemotherapy for resectable liver metastases from colorectal cancer

Age dependent increase in median and long-term survival in 29 628 metastatic colorectal cancer (mcrc) scandinavian patients during the past two decades

Qvortrup, C.; Cvancarova, M.; Glimelius, Bengt; Pfeiffer, P. et al.

Ingår i Annals of Oncology, s. 188-188, 2012

Which Rectal Cancers Are Locally Advanced?

Glimelius, Bengt

Ingår i Oncology, s. 743-+, 2012

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Schmoll, H. J.; Van Cutsem, E.; Stein, A.; Valentini, V. et al.

Ingår i Annals of Oncology, s. 2479-2516, 2012

• DOI för ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Evaluation of predictive markers for patients with advanced colorectal cancer

Byström, Per; Berglund, Åke; Nygren, Peter; Wernroth, Lisa et al.

Ingår i Acta Oncologica, s. 849-859, 2012

• DOI för Evaluation of predictive markers for patients with advanced colorectal cancer

Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer

Pettersson, D.; Holm, T.; Iversen, H.; Blomqvist, L. et al.

Ingår i British Journal of Surgery, s. 577-583, 2012

• DOI för Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer

Radiation response in colorectal cancer cells

Sahlberg, Sara Haggblad; Gustafsson, Ann-Sofie; Glimelius, Bengt; Stenerlöw, Bo

Ingår i International Journal of Molecular Medicine, 2012

Dummy Run in the Phase III LAP07 Pancreatic Cancer Trial: First Evaluation of Quality of Radiation Therapy Planning

Racadot, S.; Hammel, P.; Chibaudel, B.; Goldstein, D. et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, 2012

Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity

Rasmussen, Markus; Sundström, Magnus; Kultima, Hanna Göransson; Botling, Johan et al.

Ingår i Genome Biology, 2011

• DOI för Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
• Ladda ner fulltext (pdf) av Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity

Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival

Birgisson, Helgi; Wallin, Ulrik; Holmberg, Lars; Glimelius, Bengt

Ingår i BMC Cancer, s. 438, 2011

• DOI för Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
• Ladda ner fulltext (pdf) av Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

van Gijn, Willem; Marijnen, Carrie A. M.; Nagtegaal, Iris D.; Kranenbarg, Elma Meershoek-Klein et al.

Ingår i The Lancet Oncology, s. 575-582, 2011

• DOI för Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma

Smedby, Karin E.; Foo, Jia Nee; Skibola, Christine F.; Darabi, Hatef et al.

Ingår i PLoS Genetics, 2011

• DOI för GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma

The Effects of Short-Course Preoperative Irradiation on Local Recurrence Rate and Survival in Rectal Cancer: A Population-Based Nationwide Study

Tiefenthal, Marit; Nilsson, Per J.; Johansson, Robert; Glimelius, Bengt et al.

Ingår i Diseases of the Colon & Rectum, s. 672-680, 2011

• DOI för The Effects of Short-Course Preoperative Irradiation on Local Recurrence Rate and Survival in Rectal Cancer: A Population-Based Nationwide Study

Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer

Frederiksen, C.; Qvortrup, C.; Christensen, I. J.; Glimelius, Bengt et al.

Ingår i Annals of Oncology, s. 369-375, 2011

• DOI för Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer

Tumour budding correlates with local recurrence of rectal cancer

Syk, E.; Lenander, C.; Nilsson, P. J.; Rubio, C. A. et al.

Ingår i Colorectal Disease, s. 255-262, 2011

• DOI för Tumour budding correlates with local recurrence of rectal cancer

EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy

Wei, Q.; Shui, Y.; Zheng, S.; Wester, Kenneth et al.

Ingår i Oncology Reports, s. 3-11, 2011

• DOI för EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy

Communication analysis in oncology care: Performance of a combination of a content analysis system and a global scale

Fagerlind, Hanna; Bergström, Ida; Kettis, Åsa; Velikova, Galina et al.

Ingår i Psycho-Oncology, s. 992-1000, 2011

• DOI för Communication analysis in oncology care: Performance of a combination of a content analysis system and a global scale

And they lived happily ever after… The marriage of Nordic Association for Clinical Physics and Acta Oncologica

Muren, Ludvig P; Glimelius, Bengt

Ingår i Acta Oncologica, s. 835-837, 2011

• DOI för And they lived happily ever after… The marriage of Nordic Association for Clinical Physics and Acta Oncologica

Particle therapy: a next logical step in the improvement of radiotherapy

Nyström, Håkan; Blomqvist, Erik; Høyer, Morten; Montelius, Anders et al.

Ingår i Acta Oncologica, s. 741-744, 2011

• DOI för Particle therapy: a next logical step in the improvement of radiotherapy

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer

Wallin, Ulrik; Glimelius, Bengt; Jirström, K.; Darmanis, Spyros et al.

Ingår i British Journal of Cancer, s. 1619-1627, 2011

• DOI för Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer

Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer

Glimelius, Bengt; Garmo, Hans; Berglund, Åke; Fredriksson, L. A. et al.

Ingår i The Pharmacogenomics Journal, s. 61-71, 2011

• DOI för Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer

Socioeconomic inequalities in the use of radiotherapy for rectal cancer: A nationwide study

Olsson, L. I.; Granström, F.; Glimelius, Bengt

Ingår i European Journal of Cancer, s. 347-353, 2011

• DOI för Socioeconomic inequalities in the use of radiotherapy for rectal cancer: A nationwide study

Mesorectal Fascia Instead of Circumferential Resection Margin in Preoperative Staging of Rectal Cancer

Glimelius, Bengt; Beets-Tan, Regina; Blomqvist, Lennart; Brown, Gina et al.

Ingår i Journal of Clinical Oncology, s. 2142-2143, 2011

• DOI för Mesorectal Fascia Instead of Circumferential Resection Margin in Preoperative Staging of Rectal Cancer

Differences according to educational level in the management and survival of colorectal cancer in Sweden

Cavalli-Björkman, Nina; Lambe, Mats; Eaker, Sonja; Sandin, Fredrik et al.

Ingår i European Journal of Cancer, s. 1398-1406, 2011

• DOI för Differences according to educational level in the management and survival of colorectal cancer in Sweden

Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer

Wettergren, Lena; Kettis, Åsa; Glimelius, Bengt; Ring, Lena

Ingår i Acta Oncologica, s. 648-652, 2011

• DOI för Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

Magnusson, Kristina; de Wit, Meike; Brennan, Donal J.; Johnson, Louis B. et al.

Ingår i American Journal of Surgical Pathology, s. 937-948, 2011

• DOI för SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

Novel activity of acriflavine against colorectal cancer tumor cells

Hassan, Saadia; Laryea, Daniel; Mahteme, Haile; Felth, Jenny et al.

Ingår i Cancer Science, s. 2206-2213, 2011

• DOI för Novel activity of acriflavine against colorectal cancer tumor cells

Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: Results from a randomized phase III study

Braendengen, Morten; Tveit, Kjell Magne; Bruheim, Kjersti; Cvancarova, Milada et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, s. 1017-1024, 2011

• DOI för Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: Results from a randomized phase III study

Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study

Brændengen, Morten; Hansson, Karl; Radu, Calin; Siegbahn, Albert et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, 2011

• DOI för Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study

Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia

Kaderi, Mohd Arifin; Mansouri, Mahmoud; Zainuddin, Norafiza; Cahill, Nicola et al.

Ingår i Leukemia Research, s. 335-339, 2010

• DOI för Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia
• Ladda ner fulltext (pdf) av Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia

KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice

Sundström, Magnus; Edlund, Karolina; Lindell, Monica; Glimelius, Bengt et al.

Ingår i BMC Cancer, s. 660, 2010

• DOI för KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice

Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review

Torkzad, Michael R.; Påhlman, Lars; Glimelius, Bengt

Ingår i Insights into Imaging, s. 245-267, 2010

• DOI för Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review

Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer

Pettersson, D.; Cedermark, B.; Holm, T.; Radu, Calin et al.

Ingår i British Journal of Surgery, s. 580-587, 2010

• DOI för Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer

A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer

Glimelius, Bengt; Lahn, M.; Gawande, S.; Cleverly, A. et al.

Ingår i Annals of Oncology, s. 1020-1026, 2010

• DOI för A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer

Factors associated with psychological distress and grief resolution in surviving spouses of patients with advanced gastrointestinal cancer

Winterling, Jeanette; Wasteson, Elisabet; Arving, Cecilia; Johansson, Birgitta et al.

Ingår i Supportive Care in Cancer, s. 1377-1384, 2010

• DOI för Factors associated with psychological distress and grief resolution in surviving spouses of patients with advanced gastrointestinal cancer

An explorative randomised phase II study of sequential chemotherapy in advanced upper gastrointestinal cancer

Berglund, Åke; Byström, Per; Johansson, Birgitta; Nygren, Peter et al.

Ingår i Medical Oncology, s. 65-72, 2010

• DOI för An explorative randomised phase II study of sequential chemotherapy in advanced upper gastrointestinal cancer

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

Gubanski, Michael; Johnsson, Anders; Fernebro, Eva; Kadar, Lianna et al.

Ingår i Gastric Cancer, s. 155-161, 2010

• DOI för Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer

Qvortrup, Camilla; Jensen, B. V.; Fokstuen, T.; Nielsen, S. E. et al.

Ingår i Annals of Oncology, s. 87-91, 2010

• DOI för A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer

Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study

Birgisson, Helgi; Nielsen, Hans J.; Christensen, Ib Jarle; Glimelius, Bengt et al.

Ingår i European Journal of Cancer, s. 3323-3331, 2010

• DOI för Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study

An explorative study on the clinical utility of baseline and serial serum tumour marker measurements in advanced upper gastrointestinal cancer

Byström, P.; Berglund, Åke; Nygren, Peter; Wernroth, Mona-Lisa et al.

Ingår i Oncology Reports, s. 1645-1652, 2010

• DOI för An explorative study on the clinical utility of baseline and serial serum tumour marker measurements in advanced upper gastrointestinal cancer

Adjuvant chemotherapy in rectal cancer: an issue or a nonissue?

Glimelius, Bengt

Ingår i Annals of Oncology, s. 1739-1741, 2010

• DOI för Adjuvant chemotherapy in rectal cancer: an issue or a nonissue?

Any progress in pancreatic cancer? Well, but progress for Acta Oncologica

Glimelius, Bengt

Ingår i Acta Oncologica, s. 404-406, 2010

• DOI för Any progress in pancreatic cancer? Well, but progress for Acta Oncologica

Factors influencing local failure in rectal cancer: analysis of 2315 patients from a population-based series

Syk, Erik; Glimelius, Bengt; Nilsson, P. J.

Ingår i Diseases of the Colon & Rectum, s. 744-752, 2010

• DOI för Factors influencing local failure in rectal cancer: analysis of 2315 patients from a population-based series

Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study

Gunnlaugsson, Adalsteinn; Anderson, Harald; Lind, Pehr; Glimelius, Bengt et al.

Ingår i Radiotherapy and Oncology, s. 292-297, 2010

• DOI för Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study

Does socioeconomic status influence the prospect of cure from colon cancer - A population-based study in Sweden 1965-2000

Eloranta, S.; Lambert, P. C.; Cavalli-Björkman, Nina; Andersson, T. M-L et al.

Ingår i European Journal of Cancer, s. 2965-2972, 2010

• DOI för Does socioeconomic status influence the prospect of cure from colon cancer - A population-based study in Sweden 1965-2000

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

Van Cutsem, E.; Dicato, M.; Arber, N.; Berlin, J. et al.

Ingår i Annals of Oncology, s. 1-10, 2010

• DOI för Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

Evidence-based medicine: the time has come to set standards for staging

Quirke, Phil; Cuvelier, Claude; Ensari, Arzu; Glimelius, Bengt et al.

Ingår i Journal of Pathology, s. 357-360, 2010

• DOI för Evidence-based medicine: the time has come to set standards for staging

High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome

Aldulaymi, Bahir; Byström, Per; Berglund, Åke; Christensen, Ib J. et al.

Ingår i Oncology, s. 144-149, 2010

• DOI för High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome

Effects of an EGFR-binding affibody molecule on intracellular signaling pathways

Nordberg, Erika; Ekerljung, Lina; Häggblad Sahlberg, Sara; Carlsson, Jörgen et al.

Ingår i International Journal of Oncology, s. 967-972, 2010

• DOI för Effects of an EGFR-binding affibody molecule on intracellular signaling pathways

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32

Conde, Lucia; Halperin, Eran; Akers, Nicholas K.; Brown, Kevin M. et al.

Ingår i Nature Genetics, s. 661-664, 2010

• DOI för Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32

In memoriam - Lars-Gunnar Larsson 1919-2009

Glimelius, Bengt; Lindstam, Leif

Ingår i Acta Oncologica, s. 132-133, 2010

• DOI för In memoriam - Lars-Gunnar Larsson 1919-2009

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

Hjalgrim, Henrik; Rostgaard, Klaus; Johnson, Paul C. D.; Lake, Annette et al.

Ingår i Proceedings of the National Academy of Sciences of the United States of America, s. 6400-6405, 2010

• DOI för HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Glimelius, Bengt; Påhlman, Lars; Cervantes, A.

Ingår i Annals of Oncology, 2010

• DOI för Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Can DNA sampling from the rectal mucosa be a novel tool for the detection of colorectal cancer?

Wallin, Ulrik; Gunnarsson, Ulf; Glimelius, Bengt; Loktionov, Alexandre et al.

Ingår i International Journal of Colorectal Disease, s. 1071-1078, 2010

• DOI för Can DNA sampling from the rectal mucosa be a novel tool for the detection of colorectal cancer?

Rectal cancer radiotherapy: Towards European consensus

Valentini, Vincenzo; Glimelius, Bengt

Ingår i Acta Oncologica, s. 1206-1216, 2010

• DOI för Rectal cancer radiotherapy: Towards European consensus

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

Bernhard, J.; Dietrich, D.; Glimelius, Bengt; Hess, V. et al.

Ingår i British Journal of Cancer, s. 1318-1324, 2010

• DOI för Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study

Glimelius, Bengt; Spindler, K. L.; Frödin, J-E.; Berglund, Åke et al.

Ingår i Annals of Oncology, s. 1127-1128, 2010

• DOI för Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

Enciso-Mora, Victor; Broderick, Peter; Ma, Yussanne; Jarrett, Ruth F. et al.

Ingår i Nature Genetics, s. 1126-1130, 2010

• DOI för A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study

Gunnlaugsson, Adalsteinn; Anderson, Harald; Fernebro, Eva; Kjellén, Elisabeth et al.

Ingår i European Journal of Cancer, s. 807-813, 2009

• DOI för Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study

Expectations for the recovery period after cancer treatment – a qualitative study

Winterling, Jeanette; Sidenvall, Birgitta; Glimelius, Bengt; Nordin, Karin

Ingår i European Journal of Cancer Care, s. 585-593, 2009

• DOI för Expectations for the recovery period after cancer treatment – a qualitative study

Reply to FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?

Byström, P.; Glimelius, Bengt

Ingår i Annals of Oncology, s. 1150-1150, 2009

• DOI för Reply to FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?

The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer

Birgisson, Helgi; Ghanipour, Arezo; Smedh, Kennet; Påhlman, Lars et al.

Ingår i Familial Cancer, s. 555-561, 2009

• DOI för The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer

The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer

Ghanipour, Arezo; Jirström, Karin; Pontén, Fredrik; Glimelius, Bengt et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 2949-2956, 2009

• DOI för The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer

Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients

Sorbye, Halfdan; Pfeiffer, Per; Cavalli-Björkman, Nina; Qvortrup, Camilla et al.

Ingår i Cancer, s. 4679-87, 2009

• DOI för Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients

Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma

Biggar, Robert J.; Christiansen, Michael; Rostgaard, Klaus; Smedby, Karin Ekström et al.

Ingår i International Journal of Cancer, s. 2616-20, 2009

• DOI för Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma

Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

Glimelius, Bengt; Oliveira, J.

Ingår i Annals of Oncology, s. 54-6, 2009

• DOI för Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

Byström, Per; Berglund, A.; Garske, Ulrike Garske; Jacobsson, H. et al.

Ingår i Annals of Oncology, s. 1057-1061, 2009

• DOI för Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer

Gaber, A.; Johansson, M.; Stenman, U-H.; Hotakainen, K. et al.

Ingår i British Journal of Cancer, s. 1540-1548, 2009

• DOI för High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer

Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer

Fokstuen, Tone; Holm, Torbjörn; Glimelius, Bengt

Ingår i Radiotherapy and Oncology, s. 293-297, 2009

• DOI för Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer

Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma

Worrillow, Lisa; Smith, Alex; Scott, Kathryn; Andersson, Michael et al.

Ingår i Journal of Medical Genetics, s. 142-146, 2008

• DOI för Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

Nordlinger, Bernard; Sorbye, Halfdan; Glimelius, Bengt; Poston, Graeme J et al.

Ingår i The Lancet, s. 1007-1016, 2008

• DOI för Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

Four weeks of daily assessments of anxiety, depression and activity compared to a point assessment with the Hospital Anxiety and Depression Scale

Arving, Cecilia; Glimelius, Bengt; Brandberg, Yvonne

Ingår i Quality of Life Research, s. 95-104, 2008

• DOI för Four weeks of daily assessments of anxiety, depression and activity compared to a point assessment with the Hospital Anxiety and Depression Scale

Patient-physician communication during oncology consultations

Fagerlind, Hanna; Kettis, Åsa; Bergström, Ida; Nilsson, Magdalena et al.

Ingår i Psycho-Oncology, s. 975-985, 2008

• DOI för Patient-physician communication during oncology consultations

Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer

Braendengen, Morten; Tveit, Kjell M.; Berglund, Åke; Birkemeyer, Elke et al.

Ingår i Journal of Clinical Oncology, s. 3687-3694, 2008

• DOI för Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer

Short-course preoperative radiotherapy with delayed surgery in rectal cancer: a retrospective study

Radu, Calin; Berglund, Åke; Påhlman, Lars; Glimelius, Bengt

Ingår i Radiotherapy and Oncology, s. 343-9, 2008

• DOI för Short-course preoperative radiotherapy with delayed surgery in rectal cancer: a retrospective study

Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001

Bernhard, Jürg; Dietrich, Daniel; Scheithauer, Werner; Gerber, Daniela et al.

Ingår i Journal of Clinical Oncology, s. 3695-3701, 2008

• DOI för Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001

Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma

Biggar, Robert J.; Johansen, Julia S.; Smedby, Karin Ekström; Rostgaard, Klaus et al.

Ingår i Clinical Cancer Research, s. 6974-8, 2008

• DOI för Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

Hess, Viviane; Glimelius, Bengt; Grawe, Philipp; Dietrich, Daniel et al.

Ingår i The Lancet Oncology, s. 132-8, 2008

• DOI för CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

Local recurrence in rectal cancer: anatomic localization and effect on radiation target

Syk, Erik; Torkzad, Michael R.; Blomqvist, Lennart; Nilsson, Per J. et al.

Ingår i International Journal of Radiation Oncology, Biology, Physics, s. 658-64, 2008

• DOI för Local recurrence in rectal cancer: anatomic localization and effect on radiation target

In vivo and in vitro uptake of In-111, delivered with the affibody molecule(Z(EGFR:955))(2), in EGFR expressing tumour cells

Nordberg, Erika; Orlova, Anna; Friedman, M.; Tolmachev, Vladimir et al.

Ingår i Oncology Reports, s. 853-857, 2008

The 'good', the 'bad', and the 'ugly' rectal cancers.

Blomqvist, Lennart; Glimelius, Bengt

Ingår i Acta Oncol, s. 5-8, 2008

Hepatitis C infection and risk of malignant lymphoma

Schöllkopf, Claudia; Smedby, Karin Ekström; Hjalgrim, Henrik; Rostgaard, Klaus et al.

Ingår i International Journal of Cancer, s. 1885-1890, 2008

• DOI för Hepatitis C infection and risk of malignant lymphoma

Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion

Mahteme, Haile; Wallin, I; Glimelius, Bengt; Påhlman, Lars et al.

Ingår i European Journal of Clinical Pharmacology, s. 907-911, 2008

• DOI för Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion

Reference dosimetry in a scanned pulsed proton beam using ionisation chambers and a Faraday cup

Lorin, Stefan; Grusell, Erik; Tilly, Nina; Medin, Joakim et al.

Ingår i Physics in Medicine and Biology, s. 3519-3529, 2008

• DOI för Reference dosimetry in a scanned pulsed proton beam using ionisation chambers and a Faraday cup

Borrelia infection and risk of non-Hodgkin lymphoma

Schöllkopf, Claudia; Melbye, Mads; Munksgaard, Lars; Smedby, Karin Ekström et al.

Ingår i Blood, s. 5524-5529, 2008

• DOI för Borrelia infection and risk of non-Hodgkin lymphoma

Health-related quality of life and distress in cancer patients: results from a large randomised study

Johansson, Birgitta; Brandberg, Y.; Hellbom, M.; Persson, Christina et al.

Ingår i British Journal of Cancer, s. 1975-1983, 2008

• DOI för Health-related quality of life and distress in cancer patients: results from a large randomised study

A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

Glimelius, Bengt; Sørbye, H; Balteskard, L; Byström, P et al.

Ingår i Annals of Oncology, s. 909-914, 2008

• DOI för A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

The dream of a philologist

Glimelius, Bengt

Ingår i Acta Oncologica, s. 991-993, 2008

• DOI för The dream of a philologist

The importance of expectations on the recovery period after cancer treatment

Winterling, Jeanette; Glimelius, Bengt; Nordin, Karin

Ingår i Psycho-Oncology, s. 190-198, 2008

• DOI för The importance of expectations on the recovery period after cancer treatment

Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis

Mahteme, Haile; von Heideman, Anne; Grundmark, Birgitta; Tholander, B. et al.

Ingår i European Journal of Surgical Oncology, s. 547-552, 2008

• DOI för Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis

Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?

Berglund, Åke; Cedermark, B; Glimelius, Bengt

Ingår i Annals of Oncology, s. 400-402, 2008

• DOI för Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?

Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification

Sorbye, H.; Köhne, C-H; Sargent, D. J.; Glimelius, Bengt

Ingår i Annals of Oncology, s. 1666-1672, 2007

• DOI för Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification

Individual psychosocial support for breast cancer patients: A randomized study of nurse vs. psychologist interventions and standard care

Arving, Cecilia; Sjödén, Per-Olow; Bergh, Jonas; Hellbom, Maria et al.

Ingår i Cancer Nursing, 2007

• DOI för Individual psychosocial support for breast cancer patients: A randomized study of nurse vs. psychologist interventions and standard care

Acta Oncologica--achievements during 2006 and a look at the future

Glimelius, Bengt

Ingår i Acta Oncologica, s. 5-7, 2007

• DOI för Acta Oncologica--achievements during 2006 and a look at the future

Adjuvant behandling av ventrikelcancer prövas i Sverige

Glimelius, Bengt; Lind, Pehr; Lundell, Lars

Ingår i Läkartidningen, s. 3214-3215, 2007

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Herrmann, Richard; Bodoky, György; Ruhstaller, Thomas; Glimelius, Bengt et al.

Ingår i Journal of Clinical Oncology, s. 2212-2217, 2007

• DOI för Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma

Peeters, Koen C. M.J.; Marijnen, Corrie A. M.; Nagtegaal, Iris D.; Kranenbarg, Elma Klein et al.

Ingår i Annals of Surgery, s. 693-701, 2007

• DOI för The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma

Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study

Hjalgrim, Henrik; Ekström-Smedby, Karin; Rostgaard, Klaus; Amini, Rose-Marie et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 1561-1566, 2007

• DOI för Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study

Evaluation of beta globin mRNA as an early marker of haemoglobin response to epoetin treatment

Birgegård, Gunnar; Dahl, Fredrik; Glimelius, Bengt; Landegren, Ulf

Ingår i Medical Oncology, s. 318-322, 2007

• DOI för Evaluation of beta globin mRNA as an early marker of haemoglobin response to epoetin treatment

Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry

Lambert, Paul C.; Dickman, Paul W.; Österlund, Pia; Andersson, Therese et al.

Ingår i International Journal of Cancer, s. 2052-2059, 2007

• DOI för Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry

In reply to Dr Courdi - Biologically equivalent doses (IN 2 gY/FR) TO 5 x 5 Gy

Glimelius, Bengt; Isacsson, Ulf

Ingår i Acta Oncologica, s. 396-396, 2007

• DOI för In reply to Dr Courdi - Biologically equivalent doses (IN 2 gY/FR) TO 5 x 5 Gy

A beam source model for scanned proton beams

Kimstrand, Peter; Traneus, Erik; Ahnesjö, Anders; Grusell, Erik et al.

Ingår i Physics in Medicine and Biology, s. 3151-3168, 2007

• DOI för A beam source model for scanned proton beams

Late adverse effects of radiation therapy for rectal cancer: a systematic overview

Birgisson, Helgi; Påhlman, Lars; Gunnarsson, Ulf; Glimelius, Bengt

Ingår i Acta Oncologica, s. 504-516, 2007

• DOI för Late adverse effects of radiation therapy for rectal cancer: a systematic overview

Development and verification of the pulsed scanned proton beam at the The Swedberg Laboratory in Uppsala

Tilly, Nina; Grusell, Erik; Kimstrand, Peter; Lorin, Stefan et al.

Ingår i Physics in Medicine and Biology, s. 2741-2754, 2007

• DOI för Development and verification of the pulsed scanned proton beam at the The Swedberg Laboratory in Uppsala

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule

Nordberg, Erika; Friedman, Mikaela; Göstring, Lovisa; Adams, Gregory et al.

Ingår i Nuclear Medicine and Biology, s. 609-618, 2007

• DOI för Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule

Childhood social environment and risk of non-Hodgkin lymphoma in adults

Ekström Smedby, Karin; Hjalgrim, Henrik; Chang, Ellen T.; Rostgaard, Klaus et al.

Ingår i Cancer Research, s. 11074-11082, 2007

• DOI för Childhood social environment and risk of non-Hodgkin lymphoma in adults

The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006

Verslype, C.; Van Cutsem, E.; Dicato, M.; Cascinu, S. et al.

Ingår i Annals of Oncology, 2007

• DOI för The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006

Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma

Hjalgrim, Henrik; Smedby, Karin Ekström; Rostgaard, Klaus; Molin, Daniel et al.

Ingår i Cancer Research, s. 2382-2388, 2007

• DOI för Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma

TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid

Sørensen, Nanna M; Byström, Per; Christensen, Ib J; Berglund, Åke et al.

Ingår i Clinical Cancer Research, s. 4117-4122, 2007

• DOI för TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

Sørbye, Halfdan; Berglund, Åke; Tveit, Kjell Magne; Ogreid, Dagfinn et al.

Ingår i Acta Oncologica, s. 982-988, 2007

• DOI för Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

Proton beam therapy - do we need the randomised trials and can we do them?

Glimelius, Bengt; Montelius, Anders

Ingår i Radiotherapy and Oncology, s. 105-109, 2007

• DOI för Proton beam therapy - do we need the randomised trials and can we do them?

Human papillomavirus (HPV), DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients

Laytragoon-Lewin, Nongnit; Nilsson, Per J.; Castro, Juan; Gharizadeh, Baback et al.

Ingår i Anticancer Research, s. 4473-4479, 2007

Loco-regional Recurrence from Colon Cancer: A Population-based Study

Sjövall, Annika; Granath, Fredrik; Cedermark, Björn; Glimelius, Bengt et al.

Ingår i Annals of Surgical Oncology, s. 432-440, 2007

• DOI för Loco-regional Recurrence from Colon Cancer: A Population-based Study

MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry.

Torkzad, Michael R.; Lindholm, Johan; Martling, Anna; Cedermark, Björn et al.

Ingår i European Radiology, s. 1566-1573, 2007

• DOI för MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry.

Colon cancer management and outcome in relation to individual hospitals in a defined population

Sjövall, A.; Holm, T.; Singnomklao, T.; Granath, F. et al.

Ingår i British Journal of Surgery, s. 491-499, 2007

• DOI för Colon cancer management and outcome in relation to individual hospitals in a defined population

Atopy and risk of non-Hodgkin lymphoma

Melbye, Mads; Smedby, Karin Ekström; Lehtinen, Tuula; Rostgaard, Klaus et al.

Ingår i Journal of the National Cancer Institute, s. 158-166, 2007

• DOI för Atopy and risk of non-Hodgkin lymphoma

Patients'and doctors' views of using the schedule for individual quality of life in clinical practice.

Kettis, Åsa; Ring, Lena; Widmark, Elisabeth; Bendtsen, Preben et al.

Ingår i JOURNAL OF SUPPORTIVE ONCOLOGY, s. 281-287, 2007

Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was

Sandin, Sven; Hjalgrim, Henrik; Glimelius, Bengt; Rostgaard, Klaus et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 1295-1300, 2006

• DOI för Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype

Smedby, Karin Ekström; Hjalgrim, Henrik; Askling, Johan; Chang, Ellen T. et al.

Ingår i Journal of the National Cancer Institute, s. 51-60, 2006

• DOI för Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype

Feasibility and validity of a computer administered version of SEIQoL-DW

Ring, Lena; Kettis Lindblad, Åsa; Bendtsen, P; Viklund, E et al.

Ingår i Quality of Life Research, s. 1173-1177, 2006

• DOI för Feasibility and validity of a computer administered version of SEIQoL-DW

U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.

Sambade, Clara; Berglund, Mattias; Lagercrantz, Svetlana; Sällström, Jan et al.

Ingår i Int J Cancer, s. 555-63, 2006

Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study.

Persson, Christina; Glimelius, Bengt; Rönnelid, Johan; Nygren, Peter

Ingår i Nutrition, s. 170-8, 2005

Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor.

Nordberg, Erika; Steffen, Ann-Charlott; Persson, Mikael; Sundberg, Åsa L. et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 771-7, 2005

• DOI för Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor.

Family history of hematopoietic malignancy and risk of lymphoma

Chang, Ellen T.; Ekström Smedby, Karin; Hjalgrim, Henrik; Porwit-MacDonald, Anna et al.

Ingår i Journal of the National Cancer Institute, s. 1466-1474, 2005

• DOI för Family history of hematopoietic malignancy and risk of lymphoma

Medication use and risk of non-Hodgkin's lymphoma

Chang, Ellen T.; Smedby, Karin Ekström; Hjalgrim, Henrik; Schöllkopf, Claudia et al.

Ingår i American Journal of Epidemiology, s. 965-974, 2005

• DOI för Medication use and risk of non-Hodgkin's lymphoma

Ultraviolet radiation exposure and risk of malignant lymphomas

Smedby, Karin Ekström; Hjalgrim, Henrik; Melbye, Mads; Torrång, Anna et al.

Ingår i Journal of the National Cancer Institute, s. 199-209, 2005

• DOI för Ultraviolet radiation exposure and risk of malignant lymphomas

The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer

Tilly, Nina; Johansson, Jonas; Isacsson, Ulf; Medin, Joakim et al.

Ingår i Physics in Medicine and Biology, s. 2765-2777, 2005

• DOI för The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer

Body mass index and risk of malignant lymphoma in Scandinavian men and women

Chang, Ellen T.; Hjalgrim, Henrik; Ekström Smedby, Karin; Åkerman, Måns et al.

Ingår i Journal of the National Cancer Institute, s. 210-218, 2005

• DOI för Body mass index and risk of malignant lymphoma in Scandinavian men and women

Cigarette smoking and risk of non-Hodgkin's lymphoma: a population-based case-control study

Schöllkopf, Claudia; Smedby, Karin Ekström; Hjalgrim, Henrik; Rostgaard, Klaus et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 1791-1796, 2005

• DOI för Cigarette smoking and risk of non-Hodgkin's lymphoma: a population-based case-control study

Emergency surgery for colonic cancer in a defined population

Jestin, Pia; Nilsson, J.; Heurgren, M.; Påhlman, Lars et al.

Ingår i British Journal of Surgery, s. 94-100, 2005

• DOI för Emergency surgery for colonic cancer in a defined population

Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination.

Jestin, P; Påhlman, L; Glimelius, Bengt; Gunnarsson, Ulf

Ingår i Eur J Cancer, s. 2071-8, 2005

Epidermoid anal cancer-review of a population based series of 308 consecutive patients treated according to prospective protocols.

Nilsson, PJ; Svensson, C; Goldman, S; Ljungqvist, O et al.

Ingår i Int J Radiat Oncol Biol Phys: Epidermoid anal cancer-review of a population based series of 308 consecutive patients treated according to prospective protocols., s. 92-102, 2005

Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.

Smedby, K E; Akerman, M; Hildebrand, H; Glimelius, B et al.

Ingår i Gut, s. 54-9, 2005

Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.

Glimelius, Bengt; Dahl, Olav; Cedermark, Björn; Jakobsen, Anders et al.

Ingår i Acta Oncol, s. 904-12, 2005

Occurrence of second cancers in patients treated with radiotherapy for rectal cancer.

Birgisson, Helgi; Pahlman, Lars; Gunnarsson, Ulf; Glimelius, Bengt

Ingår i J Clin Oncol, s. 6126-31, 2005

Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial.

Birgisson, Helgi; Pahlman, Lars; Gunnarsson, Ulf; Glimelius, Bengt

Ingår i J Clin Oncol, s. 8697-705, 2005

Improved survival in cancer of the colon and rectum in Sweden.

Birgisson, H; Talbäck, M; Gunnarsson, U; Påhlman, L et al.

Ingår i Eur J Surg Oncol, s. 845-53, 2005

The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus.

Valentini, Vincenzo; Glimelius, Bengt; Minsky, Bruce D; Van Cutsem, Eric et al.

Ingår i Radiother Oncol, s. 241-50, 2005

Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.

Folkesson, Joakim; Birgisson, Helgi; Pahlman, Lars; Cedermark, Bjorn et al.

Ingår i J Clin Oncol, s. 5644-50, 2005

Alcohol intake and risk of non-Hodgkin lymphoma in men and women

Chang, Ellen T.; Ekström Smedby, Karin; Zhang, Shumin M.; Hjalgrim, Henrik et al.

Ingår i Cancer Causes and Control, s. 1067-1076, 2004

• DOI för Alcohol intake and risk of non-Hodgkin lymphoma in men and women

Determinants of cancer patients' utilization of hospital care within two years after diagnosis.

Johansson, Birgitta; Holmberg, Lars; Berglund, Gunilla; Sjöden, P-O et al.

Ingår i Acta Oncol, s. 536-44, 2004

The circular stapling device as a risk factor for anastomotic leakage.

Folkesson, J; Nilsson, J; Påhlman, L; Glimelius, B et al.

Ingår i Colorectal Dis, s. 275-9, 2004

Substantial changes in life: perceptions in patients with newly diagnosed advanced cancer and their spouses.

Winterling, Jeanette; Wasteson, Elisabet; Glimelius, Bengt; Sjödén, Per-Olow et al.

Ingår i Cancer Nurs, s. 381-8, 2004

Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.

Byström, P; Frödin, J-E; Berglund, A; Wilking, Nils et al.

Ingår i Radiother Oncol, s. 171-5, 2004

The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study.

Sjövall, A; Järv, V; Blomqvist, L; Singnomklao, T et al.

Ingår i Eur J Surg Oncol, s. 834-41, 2004

Long-term sequelae after cancer therapy--a necessary consequence of success?

Glimelius, Bengt

Ingår i Acta Oncol, s. 132-3, 2004

Elective surgery for colorectal cancer in a defined Swedish population.

Jestin, P; Heurgren, M; Påhlman, L; Glimelius, Bengt et al.

Ingår i Eur J Surg Oncol, s. 26-33, 2004

Low evidence of radiation therapy in prostate cancer--a plea for intensified scientific activity.

Glimelius, Bengt; Steineck, Gunnar

Ingår i Acta Oncol, s. 311-5, 2004

Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.

Johansson, Jonas; Blomquist, Erik; Montelius, Anders; Isacsson, Ulf et al.

Ingår i Radiother Oncol, s. 129-38, 2004

A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer.

Schoemaker, N E; Kuppens, I E L M; Moiseyenko, V; Glimelius, Bengt et al.

Ingår i Br J Cancer, s. 1434-41, 2004

Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study.

Mahteme, H; Hansson, J; Berglund, Åke; Påhlman, Lars et al.

Ingår i Br J Cancer, s. 403-7, 2004

A phase II study of UFT and Leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer.

Gyldenkerne, Niels; Glimelius, Bengt; Frödin, Jan Erik; Kjaer, Mogens et al.

Ingår i Acta Oncol, s. 276-9, 2004

Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer.

Sörbye, Halfdan; Glimelius, Bengt; Berglund, Ake; Fokstuen, Tone et al.

Ingår i J Clin Oncol, s. 31-8, 2004

Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease

Travis, Lois B; Hill, Deirdre A; Dores, Graça M; Gospodarowicz, Mary et al.

Ingår i Journal of the American Medical Association (JAMA), s. 465-475, 2003

• DOI för Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease

A population-based study of the outcome for patients with first relapse of Hodgkin lymphoma

Amini, Rose-Marie; Glimelius, Bengt; Gustavsson, Anita; Ekman, Tor et al.

Ingår i European Journal of Haematology, s. 225-232, 2002

• DOI för A population-based study of the outcome for patients with first relapse of Hodgkin lymphoma

Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival

Amini, Rose-Marie; Enblad, Gunilla; Engström, Peter; Christensson, Birger et al.

Ingår i Leukemia and Lymphoma, s. 1253-1260, 2002

• DOI för Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival

A novel B-cell line (U-2932) established from a patient with a diffuse large B-cell lymphoma following Hodgkin lymphoma

Amini, Rose-Marie; Berglund, Mattias; Rosenquist, Richard; von Heideman, Anne et al.

Ingår i Leukemia and Lymphoma, s. 2179-2189, 2002

• DOI för A novel B-cell line (U-2932) established from a patient with a diffuse large B-cell lymphoma following Hodgkin lymphoma

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

Molin, Daniel; Edström, Annika; Glimelius, Ingrid; Glimelius, Bengt et al.

Ingår i British Journal of Haematology, s. 122-124, 2002

• DOI för Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

Travis, Lois B; Gospodarowicz, Mary; Curtis, Rochelle E; Clarke, E Aileen et al.

Ingår i Journal of the National Cancer Institute, s. 182-192, 2002

Raltitrexed: current clinical status and future directions

Van Cutsem, E; Cunningham, D; Maroun, J; Cervantes, A et al.

Ingår i Annals of Oncology, s. 513-522, 2002

• DOI för Raltitrexed: current clinical status and future directions

Childbearing and the risk of leukemia in Sweden

Ekström, Karin; Wuu, Joanne; Hsieh, Chung-Cheng; Glimelius, Bengt et al.

Ingår i Cancer Causes & Control, s. 47-53, 2002

Radiation therapy through activation of stable nuclides.

Carlsson, Jörgen; Forssell-Aronsson, Eva; Glimelius, Bengt

Ingår i Acta Oncol, s. 629-34, 2002

Treatment outcome in patients younger than 60 years with advanced stages (IIB-IV) of Hodgkin's disease: the Swedish National Health Care Programme experience

Amini, Rose-Marie; Enblad, Gunilla; Gustavsson, Anita; Ekman, Tor et al.

Ingår i European Journal of Haematology, s. 379-389, 2000

• DOI för Treatment outcome in patients younger than 60 years with advanced stages (IIB-IV) of Hodgkin's disease: the Swedish National Health Care Programme experience

Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden)

Adami, Johanna; Nyrén, Olof; Bergström, Reinhold; Ekbom, Anders et al.

Ingår i Cancer Causes and Control, s. 49-56, 1998

• DOI för Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden)

Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients

Amini, Rose-Marie; Enblad, Gunilla; Sundström, Christer; Glimelius, Bengt

Ingår i International Journal of Cancer, s. 510-516, 1997

• DOI för Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients

Maternal and perinatal risk factors for childhood brain tumors (Sweden)

Linet, Martha S.; Gridley, Gloria; Cnattingius, Sven; Nicholson, H. Stacy et al.

Ingår i Cancer Causes and Control, s. 437-448, 1996

• DOI för Maternal and perinatal risk factors for childhood brain tumors (Sweden)

Second cancer is the leading cause of death, with no increase of cardiovascular deaths, after combined modality Hodgkin lymphoma treatment

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt et al.

Recent advances in rectal cancer treatment: are we on the right track?

Glimelius, Bengt

Ingår i Upsala Journal of Medical Sciences, 2024

• DOI för Recent advances in rectal cancer treatment: are we on the right track?
• Ladda ner fulltext (pdf) av Recent advances in rectal cancer treatment: are we on the right track?

Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control

Prata, Ilaria; Eriksson, Martina; Krdzalic, Jasenko; Kranenbarg, Elma Meershoek-Klein et al.

Ingår i Insights into Imaging, 2023

• DOI för Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control
• Ladda ner fulltext (pdf) av Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control

Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone

Glimelius, Bengt; Stintzing, Sebastian; Marshall, John; Yoshino, Takayuki et al.

Ingår i Cancer Treatment Reviews, 2021

• DOI för Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone
• Ladda ner fulltext (pdf) av Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone

Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses

Abrahams, Harriët J. G.; Knoop, Hans; Schreurs, Maartje; Aaronson, Neil K. et al.

Ingår i Psycho-Oncology, s. 1772-1785, 2020

• DOI för Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses

Recurrence Risk after Radical Colorectal Cancer Surgery: Less Than before, But How High Is It?

Osterman, Erik; Hammarström, Klara; Imam, Israa; Österlund, Emerik et al.

Ingår i Cancers, 2020

• DOI för Recurrence Risk after Radical Colorectal Cancer Surgery: Less Than before, But How High Is It?
• Ladda ner fulltext (pdf) av Recurrence Risk after Radical Colorectal Cancer Surgery: Less Than before, But How High Is It?

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients

Glimelius, Bengt; Osterman, Erik

Ingår i Cancers, 2020

• DOI för Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
• Ladda ner fulltext (pdf) av Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients

Effects and moderators of coping skills training on symptoms of depression and anxiety in patients with cancer: Aggregate data and individual patient data meta-analyses

Buffart, L. M.; Schreurs, M. A. C.; Abrahams, H. J. G.; Kalter, J. et al.

Ingår i Clinical Psychology Review, 2020

• DOI för Effects and moderators of coping skills training on symptoms of depression and anxiety in patients with cancer: Aggregate data and individual patient data meta-analyses

Adjuvant chemotherapy in rectal cancer: state of the art and future perspectives

Glimelius, Bengt

Ingår i Current Opinion in Oncology, s. 377-383, 2020

• DOI för Adjuvant chemotherapy in rectal cancer: state of the art and future perspectives

Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review

Goey, Kaitlyn K. H.; Mahmoud, Remi; Sørbye, Halfdan; Glimelius, Bengt et al.

Ingår i European Journal of Cancer, s. 115-124, 2018

• DOI för Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review

Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs

Kalter, J.; Verdonck-de Leeuw, I. M.; Sweegers, M. G.; Aaronson, N. K. et al.

Ingår i Psycho-Oncology, s. 1150-1161, 2018

• DOI för Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs

Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease

ter Veer, Emil; van Rijssen, L. Bengt; Besselink, Marc G.; Mali, Rosa M. A. et al.

Ingår i The Lancet Oncology, 2018

• DOI för Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease

On a prolonged interval between rectal cancer (chemo) radiotherapy and surgery

Glimelius, Bengt

Ingår i Upsala Journal of Medical Sciences, s. 1-10, 2017

• DOI för On a prolonged interval between rectal cancer (chemo) radiotherapy and surgery
• Ladda ner fulltext (pdf) av On a prolonged interval between rectal cancer (chemo) radiotherapy and surgery

Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature

Bockelman, Camilla; Engelmann, Bodil E.; Kaprio, Tuomas; Hansen, Torben F. et al.

Ingår i Acta Oncologica, s. 5-16, 2015

• DOI för Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

Papamichael, D.; Audisio, R. A.; Glimelius, Bengt; de Gramont, A. et al.

Ingår i Annals of Oncology, s. 463-476, 2015

• DOI för Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Bonnetain, Franck; Bonsing, Bert; Conroy, Thierry; Dousseau, Adelaide et al.

Ingår i European Journal of Cancer, s. 2983-2993, 2014

• DOI för Guidelines for time-to-event end-point definitions in trials for pancreatic cancer: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Quality assurance and quality control for radiotherapy/medical oncology in Europe: Guideline development and implementation

Valentini, V.; Glimelius, Bengt; Frascino, V.

Ingår i European Journal of Surgical Oncology, s. 938-944, 2013

• DOI för Quality assurance and quality control for radiotherapy/medical oncology in Europe: Guideline development and implementation

Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology

Glimelius, Bengt; Lahn, M.

Ingår i Annals of Oncology, s. 1717-1725, 2011

• DOI för Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

Valentini, Vincenzo; Aristei, Cynthia; Glimelius, Bengt; Minsky, Bruce D et al.

Ingår i Radiotherapy and Oncology, s. 148-163, 2009

• DOI för Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

Treatment of the elderly colorectal cancer patient: SIOG expert recommendations

Papamichael, D.; Audisio, R.; Horiot, J. -C; Glimelius, Bengt et al.

Ingår i Annals of Oncology, s. 5-16, 2009

• DOI för Treatment of the elderly colorectal cancer patient: SIOG expert recommendations

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

Nordlinger, B.; Van Cutsem, E.; Gruenberger, T.; Glimelius, Bengt et al.

Ingår i Annals of Oncology, s. 985-992, 2009

• DOI för Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer?: A report from the European Colorectal Metastases Treatment Group

Nordlinger, Bernard; Van Cutsem, Eric; Rougier, Philippe; Köhne, Claus-Henning et al.

Ingår i European Journal of Cancer, s. 2037-2045, 2007

• DOI för Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer?: A report from the European Colorectal Metastases Treatment Group

Rectal cancer irradiation. Long course, short course or something else?

Glimelius, Bengt

Ingår i Acta Oncol, s. 1013-7, 2006

Role of radiotherapy

Påhlman, Lars; Glimelius, Bengt

Ingår i International Handbook of colorectal cancer, s. 57-70, Euromed Communications Ltd, 2008

Role of radiotherapy

Påhlman, Lars; Glimelius, Bengt

Ingår i International Handbook of Colorectal Cancer, s. 57-70, Euromed Commincations Ltd, 2008

Prognostic significance of SATB1 expression in metastatic colorectal cancer: A Nordic prospective cohort study.

Siesing, Christina; Sorbye, Halfdan; Dragomir, Anca; Pfeiffer, Per et al.

Ingår i ASCO 2018 Gastrointestinal Cancers Symposium, s. 707-707, 2018

• DOI för Prognostic significance of SATB1 expression in metastatic colorectal cancer: A Nordic prospective cohort study.

Expression of podocalyxin-like protein and epidermal growth factor receptor in metastatic colorectal cancer: Prognostic impact and relationship with response to cetuximab.

Larsson, Anna; Karnevi, Emelie; Nodin, Bjorn; Sorbye, Halfdan et al.

2018

BM and CEA as Serum Markers in Detecting Colorectal Cancer Recurrence: A Comparative Study

D, J; Osterman, Erik; C, C; G, M et al.

Impact of new MRI-guidelines on nodal staging and the use of preoperative (chemo)radiotherapy in rectal cancer

Collin, Åsa; Folkesson, Joakim; Glimelius, Bengt

Primary tumor location, molecular alterations, treatment, and outcome in a population-based metastatic colorectal cancer cohort

Osterlund, Emerik; Hammarström, Klara; Nunes, Luís; Mathot, Lucy et al.

Prognostic whole-genome and transcriptome signatures in colorectal cancers

Nunes, Luís; Li, Fuqiang; Wu, Meizhen; Luo, Tian et al.